XYBERNAUT CORP
S-8, 2000-01-12
COMPUTER COMMUNICATIONS EQUIPMENT
Previous: COLLAGENEX PHARMACEUTICALS INC, SC 13G/A, 2000-01-12
Next: XYBERNAUT CORP, S-3/A, 2000-01-12



    As filed with the Securities and Exchange Commission on January 11, 2000
                                                  Registration No. 333-_______
- --------------------------------------------------------------------------------
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      UNDER
                           THE SECURITIES ACT OF 1933
                                ----------------

                              XYBERNAUT CORPORATION
             (Exact name of registrant as specified in its charter)

               DELAWARE                                  54-1799851
(State or other jurisdiction of                       (I.R.S. Employer
incorporation or organization)                        Identification No.)

12701 FAIR LAKES CIRCLE, FAIRFAX, VIRGINIA                  22033
(Address of Principal Executive Offices)                  (Zip Code)

                        1996 OMNIBUS STOCK INCENTIVE PLAN
                            1997 STOCK INCENTIVE PLAN
                                       and
                            1999 STOCK INCENTIVE PLAN
                            (Full title of the plan)

                                EDWARD G. NEWMAN
                             12701 FAIR LAKES CIRCLE
                             FAIRFAX, VIRGINIA 22033
                                 (703) 631-6925
 (Name, address and telephone number, including area code, of agent for service)

                                 with a copy to:
                           Martin Eric Weisberg, Esq.
                       Parker Chapin Flattau & Klimpl, LLP
                           1211 Avenue of the Americas
                            New York, New York 10036
                                 (212) 704-6000

APPROXIMATE  DATE  OF  COMMENCEMENT  OF  PROPOSED  SALE  TO  PUBLIC:  As soon as
practicable after the effective date of this Registration Statement.

<TABLE>
<CAPTION>

                         CALCULATION OF REGISTRATION FEE
- ------------------------------------------------------------------------------------------------------------------------------
<S>                                          <C>                  <C>                   <C>                     <C>
                                                                     Proposed              Proposed
    Title of each class of securities          Amount To              Maximum               Maximum              Amount Of
            to be registered                 Be Registered        Aggregate Price          Aggregate            Registration
                                                                     Per Share          Offering Price              Fee
- ------------------------------------------------------------------------------------------------------------------------------
Common Stock, $.01 par value per share       5,300,000 (1)          $5.657 (2)            $29,982,100            $8,334.99
- ------------------------------------------------------------------------------------------------------------------------------
</TABLE>

<PAGE>

(1)   Pursuant to Rule  416(b),  there shall also be deemed  covered  hereby all
      additional  securities resulting from anti-dilution  adjustments under the
      1996 Omnibus Stock  Incentive  Plan, the 1997 Stock Incentive Plan and the
      1999 Stock Incentive Plan.
(2)   Estimated  solely for the  purpose of  calculating  the  registration  fee
      pursuant to Rule 457(h) and (c),  the average  ($5.657) of the closing bid
      ($5.625) and closing asked ($5.688) price on the Nasdaq SmallCap Market on
      January 6, 2000.


<PAGE>



                                     PART II

               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3.  INCORPORATION OF DOCUMENTS BY REFERENCE.

                  The  following  documents  filed  by the  registrant  with the
Securities and Exchange  Commission  (Commission  File  No.0-15086)  pursuant to
Section  13(a) of the  Securities  Exchange  Act of 1934  (the  "1934  Act") are
incorporated herein by reference:

                  (a)      The registrant's Annual Report on Form 10-KSB for the
                           year ended December 31, 1998;

                  (b)      The registrant's Quarterly Reports on Form 10-QSB for
                           the quarters ended March 31, 1999, June 30, 1999 and
                           September 30, 1999; and

                  (c)      The  description  of the  registrant's  common  stock
                           contained in the registrant's  registration statement
                           on Form SB-2/A filed on July  15,1996,  including any
                           amendment or report filed for the purpose of updating
                           such descriptions.

                  All   documents   filed   subsequent   to  the  date  of  this
registration statement pursuant to Section 13(a), 13(c), 14 or 15(d) of the 1934
Act and prior to the filing of a  post-effective  amendment which indicates that
all securities  offered have been sold or which  deregisters all securities then
remaining  unsold,  shall be  deemed to be  incorporated  by  reference  in this
registration  statement  and to be a part  hereof from the date of the filing of
such documents.  Any statement contained in a document incorporated or deemed to
be incorporated herein by reference shall be deemed to be modified or superseded
for  purposes  of this  registration  statement  to the extent  that a statement
contained herein or in any other subsequently filed document which also is or is
deemed to be  incorporated  by  reference  herein  modifies or  supersedes  such
statement.

ITEM 4.  DESCRIPTION OF SECURITIES.

                  Not  required,  inasmuch as the  registrant's  common stock is
registered under Section 12 of the Exchange Act.

ITEM 5.  INTERESTS OF NAMED EXPERTS AND COUNSEL.

                  Not Applicable.


<PAGE>


ITEM 6.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

                  The description of the  indemnification and insurance provided
to the officers and directors of the Registrant  contained under "Management" in
the  registrant's  registration  statement  on  Form  SB-2/A  (Registration  No.
333-04156) is hereby incorporated by reference.

ITEM 7.  EXEMPTION FROM REGISTRATION CLAIMED.

                  Not Applicable.

ITEM 8.  EXHIBITS.

                  See Exhibit Index on page 9 of this registration statement.

ITEM 9.  UNDERTAKINGS.

                  The undersigned registrant hereby undertakes:

                  (1) To file,  during any  period in which  offers or sales are
being made, a post-effective amendment to this Registration Statement:

                      (i)        To include any prospectus required by Section
                                 10(a)(3) of the Securities Act of 1933;

                      (ii)       To reflect in the prospectus any facts or
                                 events arising after the effective date of this
                                 registration statement (or the most recent
                                 post-effective amendment thereof) which,
                                 individually or in the aggregate, represent a
                                 fundamental change in the information set forth
                                 in this registration statement, notwithstanding
                                 the foregoing, any increase or decrease in
                                 volume of securities offered if the total
                                 dollar value of securities offered would not
                                 exceed that which was registered) and any
                                 deviation from the low or high end of the
                                 estimated maximum offering range may be
                                 reflected in the form of prospectus filed with
                                 the Commission pursuant to Rule 424(b) if, in
                                 the aggregate, the changes in volume and price
                                 represent no more than 20 percent change in the
                                 maximum aggregate offering price set forth in
                                 "Calculation of Registration Fee" table in the
                                 effective registration statement;

                      (iii)      To include any material information with
                                 respect to the plan of distribution not
                                 previously disclosed in this registration
                                 statement or any material change to such
                                 information in this Registration Statement;

<PAGE>


provided,  however,  that  paragraphs  (1)(i)  and  (1)(ii)  do not apply if the
registration statement is on Form S-3, Form S-8, and the information required to
be included in a  post-effective  amendment by those  paragraphs is contained in
periodic reports filed by the Registrant  pursuant to Section 13 or 15(d) of the
Securities  Exchange  Act of 1934  that are  incorporated  by  reference  in the
registration statement.

                  (2) That, for the purpose of determining  any liability  under
the Securities Act, each such  post-effective  amendment shall be deemed to be a
new registration  statement relating to the securities offered therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

                  (3) To remove from  registration by means of a  post-effective
amendment  any of the  securities  being  registered  which remain unsold at the
termination of the offering.

                  The  undersigned   registrant   hereby  undertakes  that,  for
purposes of determining  any liability  under the Securities Act, each filing of
the registrant's annual report pursuant to Section 13(a) or Section 15(d) of the
Securities  Exchange  Act of 1934  that is  incorporated  by  reference  in this
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities  offered herein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

                  Insofar as indemnification  for liabilities  arising under the
Securities Act may be permitted to directors,  officers and controlling  persons
of the  registrant  pursuant to the  foregoing  provisions  described  in Item 6
above, or otherwise,  the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy
as expressed in the  Securities  Act and is,  therefore,  unenforceable.  In the
event that a claim for indemnification  against such liabilities (other than the
payment by the registrant of expenses incurred or paid by a director, officer or
controlling  person of the registrant in the  successful  defense of any action,
suit or proceeding) is asserted by such director,  officer or controlling person
in connection with the securities being registered,  the registrant will, unless
in the  opinion  of its  counsel  the matter  has been  settled  by  controlling
precedent,  submit to a court of appropriate  jurisdiction  the question whether
such  indemnification  by it is  against  public  policy  as  expressed  in  the
Securities Act and will be governed by the final adjudication of such issue.

<PAGE>




                                   SIGNATURES

                   Pursuant to the  requirements  of the Securities Act of 1933,
the registrant certifies that it has reasonable grounds to believe that it meets
all of the  requirements  for  filing  on  Form  S-8 and has  duly  caused  this
registration statement to be signed on its behalf by the undersigned,  thereunto
duly authorized, in the City of Fairfax, the Commonwealth of Virginia on January
6, 2000.

                                            XYBERNAUT CORPORATION



                                            By: /s/ Edward G. Newman
                                                ------------------------
                                                Edward G. Newman
                                                Chairman of the Board, President
                                                and Chief Executive Officer

                   KNOW  ALL MEN BY  THESE  PRESENTS,  that  each  person  whose
signature below  constitutes and appoints each of Edward G. Newman and Steven A.
Newman his true and lawful  attorney-in-fact  and agent, each with full power of
substitution  and  resubstitution,  for him and in his name, place and stead, in
any and all capacities, to sign any and all amendments (including post-effective
amendments)  to this  registration  statement,  and to file the  same,  with all
exhibits  thereto  and  other  documents  in  connection  therewith,   with  the
Securities and Exchange Commission, granting unto each said attorney-in-fact and
agent,  full power and  authority to do and perform each and every act and thing
requisite  or necessary  to be done in and about the  premises,  as fully to all
intents and  purposes as he might or could do in person,  hereby  ratifying  and
confirming all that said  attorney-in-fact  and agent or either of them or their
or his substitute or substitutes,  may lawfully do or cause to be done by virtue
hereof.

                   Pursuant to the  requirements  of the Securities Act of 1933,
this  Registration  Statement has been signed below by the following  persons in
the capacities indicated on the 6th day of January, 2000.


         Signature                               Title
         ---------                               -----



By:/s/ Edward G. Newman            Chairman of the Board, President and Chief
   -----------------------         Executive Officer
     Edward G. Newman


By:/s/ Martin Eric Weisberg        Secretary and Director
  -------------------------
     Martin Eric Weisberg

<PAGE>

By: /s/ Lt. Gen. Harry E. Soyster  Director
   ------------------------------
     Lt. Gen. Harry E. Soyster


By:/s/ James J. Ralabate           Director
   -----------------------------
     James J. Ralabate


By: /s/ Keith P. Hicks             Director
   -----------------------------
     Keith P. Hicks


By: /s/ Steven A. Newman           Director
   -----------------------------
     Steven A. Newman


By:/s/ Phillip E. Pearce           Director
   ------------------------------
     Phillip E. Pearce


By:/s/ Eugene J. Amobi             Director
   ------------------------------
     Eugene J. Amobi



*By:/s/ Edward G. Newman           Director
    -----------------------------
        Edward G. Newman
       Attorney-in-fact

<PAGE>


                                 SECURITIES AND
                                    EXCHANGE
                                   COMMISSION

                             WASHINGTON, D.C. 20549


                                  -------------




                                    EXHIBITS
                                       TO
                             REGISTRATION STATEMENT
                                       ON
                                    FORM S-8
                                      UNDER
                           THE SECURITIES ACT OF 1933


                                  -------------







                              XYBERNAUT CORPORATION
                       (EXACT NAME OF ISSUER AS SPECIFIED
                                 IN ITS CHARTER)



                                 JANUARY 6, 2000


<PAGE>


                                  EXHIBIT INDEX

<TABLE>
<CAPTION>

Exhibit
Number       Description
- ------       -----------
<S>          <C>
5.1          Opinion of Parker Chapin Flattau & Klimpl, LLP, as to the legality of the
             common stock being offered.
23.1         Consent of Parker Chapin Flattau & Klimpl, LLP (included in their opinion filed
             as Exhibit 5.1).
23.2         Consent of PricewaterhouseCoopers LLP
24.1         Power of attorney of certain officers and directors of the registrant (contained in
             the signature page).
99.1         1996 Omnibus Stock Incentive Plan.
99.2         1997 Stock Incentive Plan.
99.3         1999 Stock Incentive Plan.
</TABLE>


                                                                    EXHIBIT 5.1



                                January 11, 2000


Xybernaut Corporation
12701 Fair Lakes Circle
Fairfax, Virginia 22033

Gentlemen:

         We  have  acted  as  counsel  to  Xybernaut  Corporation,   a  Delaware
corporation  (the  "Company") in connection with its  Registration  Statement on
Form S-8 (the  "Registration  Statement")  to be filed with the  Securities  and
Exchange  Commission  relating to the  registration  of (i) 5,300,000  shares of
Common  Stock,  par value $.01 per share (the  "Common  Stock"),  of the Company
issuable  upon  exercise  of options  granted  pursuant to Section 701 under the
Securities  Act of 1933,  as amended  (the "Rule 701  Issuances");  (ii) 650,000
shares of Common  Stock  issuable  upon  exercise  of  options  granted or to be
granted under the Company's 1996 Omnibus Stock Incentive Plan (the "1996 Plan");
(iii) 1,650,000 shares of Common Stock issuable upon exercise of options granted
or to be granted  pursuant to the Company's 1997 Stock Incentive Plan (the "1997
Plan");  and (iv) 3,000,000 shares of Common Stock issuable upon the exercise of
options granted or to be granted  pursuant to the Company's 1999 Stock Incentive
Plan (the "1999 Plan").  All of such shares are collectively  referred to herein
as the "Shares".

         In connection with the foregoing, we have examined, among other things,
the agreements relating to the Rule 701 Issuances,  the 1996 Plan, the 1997 Plan
and  the  1999  Plan,  the  Registration  Statement  and  originals  or  copies,
satisfactory  to us, of all such corporate  records and of all such  agreements,
certificates  and other  documents as we have deemed relevant and necessary as a
basis  for the  opinion  hereinafter  expressed.  In such  examination,  we have
assumed the  genuineness of all  signatures,  the  authenticity of all documents
submitted to us as originals and the conformity  with the original  documents of
documents  submitted to us as copies.  As to any facts material to such opinion,
we have, to the extent that relevant facts were not independently established by
us,  relied on  certificates  of public  officials and  certificates,  oaths and
declarations of officers or other representatives of the Registrant.

         Based upon and subject to the foregoing, we are of the opinion that the
Shares to be issued pursuant to the exercise of options granted or to be granted
under the Rule 701  Issuances,  the 1996  Plan,  the 1997 Plan and the 1999 Plan
will be, when issued  pursuant to the provisions of Rule 701, the 1996 Plan, the
1997 Plan and the 1999  Plan,  as  applicable,  validly  issued,  fully paid and
non-assessable.

<PAGE>

         We hereby consent to the filing of a copy of this opinion as an exhibit
to the Registration Statement.

                                             Very truly yours,

                                         /s/ Parker Chapin Flattau & Klimpl, LLP
                                         --------------------------------------
                                          Parker Chapin Flattau & Klimpl, LLP





                                                                   EXHIBIT 23.2


                       CONSENT OF INDEPENDENT ACCOUNTANTS

We  hereby  consent  to the  incorporation  by  reference  in this  Registration
Statement  on Form S-8 of our  report  dated  April  14,  1999  relating  to the
consolidated  financial  statements,  which  appears in Xybernaut  Corporation's
Annual Report on Form 10-KSB for the year ended December 31, 1998.



/s/  PricewaterhouseCoopers LLP
McLean, Virginia
January 11, 2000


                                                                    EXHIBIT 99.1

                              XYBERNAUT CORPORATION

                        1996 OMNIBUS STOCK INCENTIVE PLAN

          1. General.  This omnibus Stock  Incentive Plan (the "Plan")  provides
eligible employees of Xybernaut Corporation (the "Company") with the opportunity
to acquire or expand  their equity  interest in the Company by making  available
for  award or  purchase  shares of $.Ol par value  common  stock of the  company
("Common Shares"),  through the granting of nontransferable  options to purchase
Common  Shares  ("Stock  Options"),  the  granting of Common  Shares  subject to
temporal   restrictions  on  transfer  and   substantial   risks  of  forfeiture
("Restricted  Stock"),  and the granting of  nontransferable  options to receive
payments based on the  appreciation  of Common Shares  ("SARs").  Stock Options,
Restricted Stock and SARs shall be collectively  referred to herein as "Grants";
an  individual  grant  of  Stock  Options,  Restricted  Stock  or SARs  shall be
individually  referred to herein as a "Grant". It is intended that key employees
may be granted,  simultaneously or from time to time, Stock Options that qualify
as incentive stock options  ("Incentive Stock Options") under Section 422 of the
Internal  Revenue Code of 1986, as amended (the "Code") or Stock Options that do
not so qualify  ("Non-qualified  Stock  Options").  No  provision of the Plan is
intended or shall be  construed  to grant  employees  alternative  rights in any
Incentive  Stock Option granted under the Plan so as to prevent such Option from
qualifying under Section 422 of the Code.

          2.  Purpose  of the  Plan.  The  purpose  of the  Plan  is to  provide
continuing  incentives  to key  employees  of the Company and of any  subsidiary
corporation of the Company,  by encouraging such key employees to acquire new or
additional share ownership in the

<PAGE>

Company, thereby increasing their proprietary interest in the Company's business
and enhancing their personal interest in the Company's success.

                  For purposes of the Plan, a "subsidiary  corporation" consists
of any  corporation  fifty  percent  (50%) of the stock of which is  directly or
indirectly  owned or controlled by the company.

          3. Effective  Date of the Plan.  The Plan shall become  effective upon
its  adoption  by the Board of  Directors,  subject to  approval by holders of a
majority of the  outstanding  shares of voting capital stock of the Company.  If
the Plan is not so approved within twelve (12) months after the date the Plan is
adopted by the Board of Directors,  the Plan and any Grants made hereunder shall
be null and void.  However,  if the Plan is so approved,  no further shareholder
approval shall be required with respect to the making of Grants  pursuant to the
Plan, except as provided in Section 12 hereof.

          4.  Administration  of the Plan. The Plan shall be administered by the
Compensation Committee of the Board of Directors of the Company, or by any other
committee  selected by such Board of Directors by majority  vote and composed of
no fewer than two (2) members of such Board of Directors (the  "Committee").  No
person  shall be  appointed  to the  Committee  who,  during the one year period
immediately  preceding such person's appointment to the Committee,  has received
any Grants under the Plan or any similar stock option or stock  incentive  plan,
other than a  formula-based  plan,  maintained by the Company or any  subsidiary
corporation.  A member of the Committee  shall not be eligible to participate in
this Plan while serving on the Committee.

<PAGE>

          A majority of the Committee shall  constitute a quorum.  The acts of a
majority of the members  present at any meeting at which a quorum is present (or
acts  unanimously  approved  in writing by the members of the  Committee)  shall
constitute binding acts of the Committee.

          Subject to the terms and conditions of the Plan,  the Committee  shall
be authorized and empowered:

          (1) To select the key employees to whom Grants may be made;

          (2) To  determine  the  number of Common  Shares to be  covered by any
Grant;

          (3) To prescribe the terms and conditions of any Grants made under the
Plan,  and the form(s) and agreement  (s) used in  connection  with such Grants,
which shall include agreements governing the granting of Restricted Stock, Stock
Options and/or SARS;

          (4) To determine the time or times when Stock Options and/or SARs will
be granted and when they will terminate in whole or in part;

          (5) To  determine  the time or times when Stock  options and SARs that
are granted may be exercised;

          (6) To  determine,  at the time a Stock  Option is  granted  under the
Plan,  whether such Option is an incentive Stock Option entitled to the benefits
of Section 422 of the Code;

          (7) To  establish  any other Stock  option  agreement  provisions  not
inconsistent  with the  terms  and  conditions  of the Plan or,  where the Stock
Option is an Incentive  Stock Option,  with the terms and  conditions of Section
422 of the  Code;  and


                                      -3-
<PAGE>

          (8) To  determine  whether  SARs  will  be  made  part  of any  Grants
consisting  of Stock  Options,  and to  approve  any SARs  made part of any such
Grants pursuant to Section 9 hereof.

          5. Employees Eligible for Grants. Grants may be made from time to time
to those key  employees  of the  Company or a  subsidiary  corporation,  who are
designated by the Committee in its sole and exclusive discretion.  Key employees
may include,  but shall not  necessarily  be limited to, members of the Board of
Directors (excluding members of the Committee), and officers, of the Company and
any  subsidiary  corporation;  however,  Stock  Options  intended  to qualify as
Incentive  Stock Options shall only be granted to key employees  while  actually
employed by the Company or a subsidiary  corporation.  The  Committee  may grant
more than one Stock Option,  with or without SARS, to the same key employee.  No
Stock Option shall be granted to any key employee during any period of time when
such key employee is on a leave of absence.

          6. Shares Subject to the Plan. The shares to be issued pursuant to any
Grant made under the Plan shall be Common  Shares.  Either Common Shares held as
treasury  stock,  or authorized and unissued  Common Shares,  or both, may be so
issued,  in such amount or amounts  within the maximum limits of the Plan as the
Board of  Directors  shall  from time to time  determine.  In the event a SAR is
granted  in tandem  with a Stock  Option  pursuant  to Section 9 and such SAR is
thereafter  exercised in whole or in part, then such Stock Option or the portion
thereof to which the duly  exercised  SAR  relates  shall be deemed to have been
exercised for purposes of such Option,  but may be made available for reoffering
under the Plan to any eligible employee.


                                      -4-
<PAGE>

                  Subject  only  to  the  provisions  of  the  next   succeeding
paragraph of this Section 6, the aggregate  number of Common Shares made subject
to all Grants under the Plan shall be six hundred and fifty  thousand  (650,000)
Common  Shares.  Such  aggregate  number of Common  Shares shall not include any
Common  Shares  reacquired  or never  issued due to a  forfeiture,  exchange  or
relinquishment of rights under a Grant made hereunder.

                  If, at any time subsequent to the date of adoption of the Plan
by the Board of  Directors,  the  number  of  common  Shares  are  increased  or
decreased, or changed into or exchanged for a different number or kind of shares
of stock or other securities of the Company or of another  corporation  (whether
as a result of a stock split, stock dividend, combination or exchange of shares,
exchange for other securities, reclassification,  reorganization, redesignation,
merger,   consolidation,   recapitalization  or  otherwise):   (i)  there  shall
automatically  be  substituted  for each Common Share subject to an  unexercised
Stock Option or SAR (in whole or in part) granted under the Plan, the number and
kind of shares of stock or other securities into which each  outstanding  Common
Share shall be changed or for which each such Common  Share shall be  exchanged;
(ii) the option price per Common Share or unit of securities  shall be increased
or  decreased  proportionately  so that the  aggregate  purchase  price  for the
securities subject to a Stock Option or SAR shall remain the same as immediately
prior  to such  event;  and  (iii)  any  outstanding  Restricted  Stock  that is
converted,  exchanged  or otherwise  changed into a different  number or kind of
stock or security, shall continue to be subject to any and all terms, conditions
and restrictions  originally applicable to such Restricted Stock. In addition to
the  foregoing,  the  Committee  shall  be  entitled  in the  event  of any such
increase, decrease or exchange of Common Shares to make other adjustments to the
securities  subject to a Stock Option or SAR, the


                                      -5-
<PAGE>

provisions  of the Plan,  and to any  related  Stock  Option  or SAR  agreements
(including  adjustments  which may provide  for the  elimination  of  fractional
shares),  where  necessary  to preserve the terms and  conditions  of any Grants
hereunder.

          7. Stock Option Provisions.

          (1) General.  The Committee may grant to key employees  (also referred
to  as  "optionees")  nontransferable  Stock  Options  that  either  qualify  as
Incentive  Stock  Options  under  Section  422 of the Code or do not so qualify.
However,  any Stock  Option  which is an  Incentive  Stock  Option shall only be
granted within 10 years from the earlier of (i) the date this Plan is adopted by
the Board of Directors of the company; or (ii) the date this Plan is approved by
the shareholders of the Company.

          (2) Stock Option Price. The option price per Common Share which may be
purchased  under an Incentive Stock Option under the Plan shall be determined by
the  Committee  at the time of Grant,  but  shall  not be less than one  hundred
percent (100%) of the fair market value of a Common Share,  determined as of the
date such Option is granted;  however,  if a key  employee to whom an  Incentive
Stock Option is granted is, at the time of the grant of such Option, an "owner,"
as defined in Section 422 (b) (6) of the Code  (modified  as provided in Section
424(d) of the Code) of more than ten percent (10!k) of the total combined voting
power of all classes of stock of the Company or any  subsidiary  corporation  (a
"Substantial  Shareholder"),  the  price per  Common  Share of such  Option,  as
determined  by the  Committee,  shall not be less than one  hundred  ten percent
(110%) of the fair  market  value of a Common  Share on the date such  option is
granted.  The option  price per Common  Share  under each Stock  Option  granted
pursuant to the Plan which is not an incentive  Stock Option shall be determined


                                      -6-
<PAGE>

by the Committee at the time of Grant.  Except as  specifically  provided above,
the fair market value of a Common Share shall be determined  in accordance  with
procedures to be established  by the  Committee.  The day on which the Committee
approves the granting of a Stock  Option shall be  considered  the date on which
such  Option  is  granted.

          (3) Period of Stock Option.  The Committee  shall  determine when each
Stock  Option  is to  expire.  However,  no  Incentive  Stock  Option  shall  be
exercisable  for a period of more than ten (10)  years  from the date upon which
such  Option is  granted.  Further,  no  Incentive  Stock  Option  granted to an
employee  who is a  Substantial  Shareholder  at the  time of the  grant of such
Option shall be  exercisable  after the expiration of (5) years from the date of
grant of such option.

          (4) Limitation on Exercise and Transfer of Stock Options. Only the key
employee to whom a Stock  Option is granted may  exercise  such  Option,  except
where a guardian or other legal  representative has been duly appointed for such
employee, and except as otherwise provided in the case of such employee's death.
No Stock Option granted  hereunder  shall be  transferable  by an optionee other
than by will or the laws of descent and  distribution.  No Stock Option  granted
hereunder may be pledged or  hypothecated,  nor shall any such Option be subject
to execution, attachment or similar process.

          (5) Employment,  Holding Period Requirements For Certain Options.  The
Committee may condition any Stock Option  granted  hereunder  upon the continued
employment  of the optionee by the Company or by a subsidiary  corporation,  and
may make any such Stock Option immediately  exercisable.  However, the Committee
will  require  that,  from and  after the date of grant of any  Incentive  Stock
Option granted  hereunder  until the day three (3) months


                                      -7-
<PAGE>

prior to the date such Option is exercised, such optionee must be an employee of
the Company or of a subsidiary  corporation,  but always subject to the right of
the  Company or any such  subsidiary  corporation  to  terminate  such  optionee
employment  during  such  period.  Each  Stock  Option  shall be subject to such
additional  restrictions  as to the  time and  method  of  exercise  as shall be
prescribed by the Committee.  Upon  completion of such  requirements,  if any, a
Stock Option or the appropriate  portion thereof may be exercised in whole or in
part from time to time during the option period; however, such exercise right(s)
shall be limited to whole shares.

          (6) Payment for Stock Option Price.  A Stock Option shall be exercised
by an optionee giving written notice to the Company of his intention to exercise
the same, accompanied by full payment of the purchase price. Such purchase price
shall be paid with cash or check,  or with a surrender of Common Shares having a
fair market value on the date of exercise  equal to that portion of the purchase
price for which payment in cash or check is not made.  The Committee may, in its
sole discretion, approve other methods of exercise for a Stock Option or payment
of the option price, provided that no such method shall cause any option granted
under the Plan as an Incentive  Stock Option to not qualify under Section 422 of
the Code, or cause any Common Share issued in connection with the exercise of an
option not to be a fully paid and nonassessable Common Share.

          (7) Certain  Reissuances of Stock Options. To the extent Common Shares
are surrendered by an optionee in connection with the exercise of a Stock Option
in accordance  with Section  7(f),  new Stock  options  shall  automatically  be
granted to such  optionee (to the extent  Common  Shares  remain  available  for
Grants);  such newly granted  stock  Options shall have the following  terms and
conditions:


                                      -8-
<PAGE>

               (1)  The number of Common  Shares shall be equal to the number of
                    Common Shares being surrendered by the optionee;

               (2)  The option price per Common Share shall be equal to the fair
                    market  value of Common  Shares,  determined  on the date of
                    exercise of the Stock  options  whose  exercise  caused such
                    Grant; and

               (3)  A majority of the Committee shall  constitute a quorum.  The
                    acts of a majority of the members  present at any meeting at
                    which a quorum is present (or acts  unanimously  approved in
                    writing by the members of the  Committee)  shall  constitute
                    binding acts of the  Committee.  The terms and conditions of
                    such Stock  Options  shall in all other  respects  replicate
                    such  terms  and  conditions  of  the  Stock  Options  whose
                    exercise caused such Grant,  except to the extent such terms
                    and conditions  are  determined not to be wholly  consistent
                    with  the  general  provisions  of  this  section  7,  or in
                    conflict with the remaining provisions of this Plan.


          (8)  Cancellation and Replacement of Stock Options and Related Rights.
The  Committee  may at any  time or  from  time to  time  permit  the  voluntary
surrender  by an optionee  who is the holder of any  outstanding  Stock  Options
under the Plan,  where such surrender is  conditioned  upon the granting to such
optionee of new Stock Options for such number of shares as the  Committee  shall
determine, or may require such a voluntary surrender as a condition precedent to
the grant of new Stock  Options.  The  Committee  shall  determine the terms and


                                      -9-
<PAGE>

conditions  of new Stock  Options,  including  the prices at and periods  during
which they may be exercised, in accordance with the provisions of this Plan, all
or any of which may differ from the terms and  conditions  of the Stock  Options
surrendered.  Any such new Stock  Options  shall be subject to all the  relevant
provisions  of this Plan.  The  Common  Shares  subject  to any Stock  Option so
surrendered  shall no longer be  charged  against  the  limitation  provided  in
Section 6 of this Plan and may again  become  shares  subject  to the Plan.  The
granting of new Stock  options in connection  with the surrender of  outstanding
Stock Options  under this Plan shall be considered  for the purposes of the Plan
as the  granting  of new  Stock  Options  and not an  alteration,  amendment  or
modification of the Plan or of the Stock options being surrendered

          (9) Limitation on Exercisable  Incentive Stock Options.  The aggregate
fair market  value of the Common  Shares first  becoming  subject to exercise as
Incentive  Stock Options by a key employee  during any given calendar year shall
not exceed the sum of one hundred  thousand dollars  ($100,000).  Such aggregate
fair  market  value shall be  determined  as of the date such Option is granted,
taking into account,  in the order in which granted,  any other  incentive stock
options granted by the Company, or by a parent or subsidiary thereof.

          8. Restricted Stock.

          (1) Grant.  The Committee  shall  determine the key employees to whom,
and the time or times at which,  Grants of  Restricted  Stock will he made,  the
number of shares of  Restricted  Stock to be  granted,  the price (if any) to be
paid by such key employees  (subject to Section 8 (b)), the time or times within
which such Restricted  Stock grants may be subject to forfeiture,  and the other
terms and  conditions  of the grants in  addition  to those set forth in Section
8(b).  The  Committee  may  condition  the grant of  Restricted  Stock  upon the
attainment of


                                      -10-
<PAGE>

specified performance goals or such other factors as the Committee may determine
in its sole discretion.

          (2) Terms and  Conditions.  Restricted  Stock  granted  under the Plan
shall contain any terms and conditions,  not inconsistent with the provisions of
the Plan,  imposed by the  Committee.  A key  employee  who  receives a grant of
Restricted  Stock shall not have any rights with  respect to such Grant,  unless
and until such key employee has executed an agreement  evidencing  such Grant in
the form  approved  from time to time by the  Committee,  has  delivered a fully
executed  copy  thereof to the  Company,  and has  otherwise  complied  with the
applicable  terms and conditions of such Grant.  In addition,  Restricted  Stock
granted under the Plan shall be subject to the following terms and conditions:


               (1)  The  purchase   price  for  Common   Shares   consisting  of
                    Restricted  Stock,  if any,  will be equal  to their  stated
                    value.

               (2)  Grants  of  Restricted  Stock  shall  only  be  accepted  by
                    executing a Restricted  Stock  agreement and paying whatever
                    price (if any) is required under Section 8(b)(i).

               (3)  Each key employee granted Restricted Stock shall be issued a
                    stock  certificate  in respect of such shares of  Restricted
                    Stock.  Such certificate  shall be registered in the name of
                    such key  employee,  and shall  bear an  appropriate  legend
                    referring  to  the  terms,   conditions,   and  restrictions
                    applicable to such Grant.

               (4)  Any stock  certificates  evidencing Common Shares consisting
                    of  Restricted  Stock shall either (A) be held in custody by
                    the


                                      -11-
<PAGE>

                    Company until the employment and other restrictions  thereon
                    shall  all have  lapsed;  or (B) be  affixed  with a legend,
                    identifying  such Shares as  Restricted  Stock and expressly
                    prohibiting the sale, transfer,  tender, pledge,  assignment
                    or  encumbrance  of  such  Shares,  as the  Committee  shall
                    determine.  With  respect  to any  Restricted  Stock held in
                    custody  by the  Company,  the  key  employee  granted  such
                    Restricted Stock shall deliver to the Company a stock power,
                    endorsed in blank, relating to the Common Shares represented
                    by such Stock.  With respect to any Restricted Stock held by
                    a key employee under legend,  the key employee  granted such
                    Restricted   Stock   shall   deliver   to  the   Company  an
                    acknowledgment   that  such  stock  remains   subject  to  a
                    substantial  risk of forfeiture in the event of  termination
                    of employment under certain circumstances.

               (5)  Subject  to the  provisions  of the Plan and the  Restricted
                    Stock  agreement,  during  a  temporal  period  set  by  the
                    Committee  and  commencing  with the date of such Grant (the
                    "Restriction Period"), a key employee shall not be permitted
                    to sell,  transfer,  tender,  pledge,  assign  or  otherwise
                    encumber  any  Restricted  Stock  granted  under  the  Plan.
                    However, the Committee, in its sole discretion,  may provide
                    for the  lapse of such  transfer  or other  restrictions  in
                    installments,  or accelerate or waive such  restrictions  in
                    whole or in


                                      -12-
<PAGE>

                    part,  based on service,  performance  or other  factors and
                    criteria selected by the Committee.

                    (6)  Except  as  provided  in this  Section  6(b)  (vi)  and
                         Section 8 (b) (v),  a key  employee  shall  have,  with
                         respect to shares of  Restricted  Stock granted to him,
                         all of the  rights  of a  shareholder  of the  Company,
                         including the right to vote such Stock and the right to
                         receive any dividends  thereon.  The Committee,  in its
                         sole  discretion  and as  determined  at the  time of a
                         Grant of Restricted  Stock,  may permit or require cash
                         dividends otherwise due and payable to be deferred and,
                         if the Committee so  determines,  reinvested  either in
                         additional  Restricted  Stock  (to  the  extent  Common
                         Shares are  available),  or otherwise.  Stock dividends
                         issued  with  respect  to  Restricted  Stock  shall  be
                         treated as additional  shares of Restricted  stock.  As
                         Restricted Stock, such additional Common Shares will be
                         subject to the same restrictions,  terms and conditions
                         applicable  to the  Restricted  Stock  with  respect to
                         which such additional Common Shares were issued.

                    (7)  No  Restricted  Stock  shall be  transferable  by a key
                         employee  other  than by will or by the laws of descent
                         and distribution.

          (3) Minimum  Value  Provisions.  To ensure  that Grants of  Restricted
Stock  reflect the  performance  of the Company and service of the key employee,
the   Committee   may   provide,   in  its   sole   discretion,   for  a  tandem
performance-based  award, or other grant, designed to

                                      -13-
<PAGE>

guarantee a minimum value, payable in cash or Common Shares, to the recipient of
a Restricted Stock Grant, subject to such performance,  future service, deferral
and other terms and conditions as may be specified by the Committee.

          9. Stock Appreciation  Rights. A key employee may be granted the right
to  receive  a payment  based on the  increase  in the  value of  common  Shares
occurring  after the date of such  Grant;  such  rights  shall be known as Stock
Appreciation  Rights  ("SARs").  SARs may (but  need  not) be  granted  to a key
employee in tandem with, and exercisable in lieu of exercising, a Grant of Stock
Options.  SARs will be  granted  upon  terms  and  conditions  specified  by the
Committee,  if  the  Company  is  the  employer  of the  key  employee,  or by a
subsidiary  corporation subject to the Committee Is approval, if such subsidiary
corporation  is the employer of the key employee.  No optionee shall be entitled
to SAR rights solely as a result of the grant of a Stock Option to him. Any such
rights,  if granted,  may only be exercised by the holder  thereof,  either with
respect to all,  or a portion,  of the Stock  Option to which it  applies.  When
granted in tandem with a Stock Option, an SAR shall provide that the holder of a
Stock  option  shall have the right to receive  an amount  equal to one  hundred
percent  (100%) of the excess,  if any,  of the fair market  value of the Common
Shares covered by such Option, determined as of the date of exercise of such SAR
by the Committee (in the same manner as such value is determined for purposes of
the granting of Stock Options), over the price to be paid for such Common Shares
under such  Option.  Such  amount  shall he payable by either the Company or the
subsidiary corporation, whichever is the employer of the key employee, in one or
more of the following manners, as determined by the Committee, if the Company is
the employer of the key employee,


                                      -14-
<PAGE>

or by the subsidiary  corporation subject to the Committee's  approval,  if such
subsidiary corporation is the employer of the key employee:

          (1) cash (or check);

          (2) fully paid Common  Shares having a fair market value equal to such
amount; or

          (3) a combination  of cash (or check) and Common  Shares.  In no event
may any person  exercise  any SARs granted  hereunder  unless (i) such person is
then permitted to exercise the Stock Option or the portion  thereof with respect
to which such SARs relate,  and -(ii) the fair market value of the Common Shares
covered by the Stock Option,  determined as provided  above,  exceeds the option
price of such Common Shares. Upon the exercise of any SARS, the Stock Option, or
that  portion  thereof  to  which  such  SARs  relate,  shall  be  canceled  and
automatically  extinguished.  A SAR  granted  in  tandem  with  a  Stock  Option
hereunder  shall be made a part of the Stock Option  agreement to which such SAR
relates,  in a form  approved by the Committee  and not  inconsistent  with this
Plan. The granting of a Stock Option or SAR shall impose no obligation  upon the
optionee to exercise  such Stock  Option or SAR.  The  Company's or a subsidiary
corporation's  obligation  to satisfy SARs shall not be funded or secured in any
manner.  No SAR granted  hereunder  shall be  transferable  by the key  employee
granted such SAR, other than by will or the laws of descent and distribution.

          After  the  Grant  of an  SAR,  an  optionee  intending  to rely on an
exemption  from  Section  16(b) of the  Securities  Exchange  Act of 1-934  (the
"Exchange  Act")  shall be required to hold such SAR for six (6) months from the
date  the  price  for  such  SAR  is  fixed  to the  date  of  cash  settlement.
Additionally, in order to remain exempt from Section 16 (b) of the Exchange


                                      -15-
<PAGE>

Act, an SAR must be exercised by an optionee subject to such Section only during
the period  beginning  on the third  business  day  following  the  release of a
summary  statement of the  Company's  quarterly or annual sales and earnings and
ending on the twelfth business day following said date.

          10.  Termination  of  Employment.  If a key  employee  ceases to be an
employee of the Company and every  subsidiary  corporation,  for a reason  other
than death,  retirement,  or permanent and total  disability,  his Grants shall,
unless  extended  by the  Committee  on or  before  his date of  termination  of
employment,  terminate on the effective date of such  termination of employment.
Neither the key  employee  nor any other  person shall have any right after such
date  to  exercise  all or any  part  of his  Stock  Options  or  SARS,  and all
Restricted Stock which is not vested or otherwise  subject to restriction  shall
thereupon be forfeited, and/or declared void and without value.

          If  termination  of  employment is due to death or permanent and total
disability,  then outstanding Stock Options and SARs may be exercised within the
one (1) year period  ending on the  anniversary  of such death or permanent  and
total disability.  In the case of death, such outstanding Stock Options and SARs
shall be exercised by such key employee's  estate,  or the person  designated by
such key employee by will, or as otherwise designated by the laws of descent and
distribution.  Notwithstanding the foregoing, in no event shall any Stock Option
or SAR be exercisable after the expiration of the option period, and in the case
of exercises made after a key employee's  death,  not to any greater extent than
the key employee  would have been entitled to exercise such Option or SAR at the
time of his death.  Restricted  Stock held by a key employee whose employment by
the Company or any  subsidiary  corporation  terminates by


                                      -16-
<PAGE>

reason  of  death  shall  thereupon  vest  and all  restrictions  and  risks  of
forfeiture thereon shall thereupon lapse.

          Subject  to the  discretion  of the  Committee,  in  the  event  a key
employee terminates employment with the Company and all subsidiary  corporations
because of normal or early  retirement  under any pension plan, or permanent and
total disability, (a) any then outstanding Stock Options and/or SAR held by such
key  employee  shall  lapse at the  earlier of the end of the term of such Stock
Option or SAR, or three (3) months after such  retirement or permanent and total
disability;  and (b) any  Restricted  Stock  held by  such  key  employee  shall
thereafter vest and any applicable  restrictions shall lapse, to the extent such
Restricted  Stock would have become vested or no longer  subject to  restriction
within one year from the time of termination  had the key employee  continued to
fulfill all of the conditions of the Restricted  Stock during such period (or on
such  accelerated  basis as the  Committee  may  determine  at or after  date of
Grant).

          In the  event an  employee  of the  Company  or one of its  subsidiary
corporations  is granted a leave of absence  by the  Company or such  subsidiary
corporation  to enter  military  service or because of sickness,  his employment
with  the  Company  or  such  subsidiary  corporation  shall  not be  considered
terminated, and he shall be deemed an employee of the Company or such subsidiary
corporation during such leave of absence or any extension thereof granted by the
Company  or such  subsidiary  corporation.

          11. Change of Control.  Upon the occurrence of a Change of Control (as
defined below),  notwithstanding any other provisions hereof or of any agreement
to the contrary, all Stock options and SARs granted under this Plan shall become
immediately  exercisable  in full


                                      -17-
<PAGE>

and  all  Restricted  Stock  grants  shall  become  immediately  vested  and any
applicable restrictions shall lapse.

          For purposes of this Plan, a Change of Control shall be deemed to have
occurred if: (i) a tender offer shall be made and  consummated for the ownership
of 25% or more of the  outstanding  voting  securities of the Company;  (ii) the
Company  shall be merged or  consolidated  with  another  corporation  and, as a
result of such merger or consolidation,  less than 75% of the outstanding voting
securities  of the  surviving  or  resulting  corporation  shall be owned in the
aggregate  by the  former  shareholders  of the  Company  as the same shall have
existed  immediately  prior to such merger or  consolidation;  (iii) the Company
shall sell  substantially all of its assets to any purchaser other then a wholly
owned subsidiary;  or (iv) a person,  within the meaning of Section 3 (a) (9) or
of Section 13(d)(3) (as in effect on the date hereof) shall acquire,  other than
by reason of inheritance,  twenty-five  percent (25%) or more of the outstanding
voting securities of the Company (whether directly, indirectly,  beneficially or
of record).  For purposes of this Plan ownership of voting securities shall take
into  account  and  shall  include  ownership  as  determined  by  applying  the
provisions of Rule  13d-3(d)(1)(i)  as in effect on the date hereof  pursuant to
the Exchange Act.

          12.  Amendments to Plan. The Committee is authorized to interpret this
Plan and from time to time adopt any rules and regulations for carrying out this
Plan  that it may  deem  advisable.  Subject  to the  approval  of the  Board of
Directors of the Company, the Committee may at any time amend,  modify,  suspend
or  terminate  this  Plan.  In  no  event,  however,  without  the  approval  of
shareholders, shall any action of the Committee or the Board of Directors result
in:


                                      -18-
<PAGE>

          (1)  Materially  amending,   modifying  or  altering  the  eligibility
requirements provided in Section 5 hereof;

          (2) Materially increasing, except as provided in Section 6 hereof, the
maximum number of shares subject to Grants; or

          (3) Materially  increasing the benefits accruing to participants under
this Plan;  except to conform  this Plan and any  agreements  made  hereunder to
changes in the Code or governing law.

          13. Investment  Representation,  Approvals and Listing.  The Committee
may, if it deems appropriate,  condition its grant of any Stock Option hereunder
upon receipt of a  representation  from the optionee which is  substantially  as
follows (and subject to modification  from time to time in the discretion of the
Committee):

          I agree that any Common  Shares of Xybernaut  Corporation  which I may
          acquire pursuant to this Stock Option shall he acquired for investment
          purposes only and not with a view to distribution  or resale,  and may
          not be transferred, sold, assigned, pledged, hypothecated or otherwise
          disposed   of  by  me  unless   (i)  a   registration   statement   or
          post-effective   amendment  to  a  registration  statement  under  the
          Securities Act of 1933, as amended, with respect to said Common Shares
          has become effective so as to permit the sale or other  disposition of
          said shares by me; or (ii) there is presented to Xybernaut Corporation
          an opinion of counsel  satisfactory  to Xybernaut  Corporation  to the
          effect  that the sale or other  proposed  disposition  of said  Common
          Shares  by me may  lawfully  be made  otherwise  than  pursuant  to an
          effective  registration  statement  or  post-effective  amendment to a
          registration   statement   relating  to  the  said  shares  under  the
          Securities Act of 1933, as amended."

          The  Company  shall  not be  required  to  issue  any  certificate  or
certificates  for Common  Shares upon the  exercise of any Stock Option or a SAR
granted  under this Plan prior to (i) the  obtaining of any approval  from any I
governmental  agency which the Company shall, in its sole discretion,  determine
to be necessary or  advisable;  (ii) the  admission of such shares to


                                      -19-
<PAGE>

listing on any national  securities  exchange on which the Common  Shares may be
listed;  (iii) the completion of any registration or other qualifications of the
Common  Shares  under any state or federal law or ruling or  regulations  of any
governmental body which the Company shall, in its sole discretion,  determine to
be  necessary  or advisable  or the  determination  by the Company,  in its sole
discretion, that any registration or other qualification of the Common Shares is
not   necessary  or   advisable;   and  (iv)  the  obtaining  of  an  investment
representation  from the optionee in the form stated above or in such other form
as the Company, in its sole discretion, shall determine to be adequate.

          14.  General  Provisions.  The form  and  substance  of  Stock  Option
agreements,  Restricted  Stock  agreements,  and SAR agreements  made hereunder,
whether granted at the same or different times,  need not be identical.  Nothing
in this Plan or in any  agreement  shall  confer upon any  employee any right to
continue in the employ of the Company or any of its subsidiary corporations,  to
be entitled to any  remuneration  or benefits not set forth in this Plan or such
Grant,  or to interfere with or limit the right of the Company or any subsidiary
corporation  to terminate  his  employment at any time,  with or without  cause.
Nothing  contained in this Plan or in any Stock Option agreement or SAR shall be
construed as entitling any optionee to any rights of a  shareholder  as a result
of the grant of a Stock Option or an SAR,  until such time as Common  Shares are
actually issued to such optionee pursuant to the exercise of such Option or SAR.
This Plan may be assumed by the  successors  and  assigns  of the  Company.  The
liability of the Company under this Plan and any sale made  hereunder is limited
to the  obligations  set forth  herein with  respect to such sale and no term or
provision of this Plan shall be construed to impose any liability on the Company
in favor of any  employee  with respect to any lose,  cost or


                                      -20-
<PAGE>

expense  which the employee may incur in  connection  with or arising out of any
transaction  in connection  with this Plan.  The cash  proceeds  received by the
Company  from the issuance of Common  Shares  pursuant to this Plan will be used
for general corporate purposes.  The expense of administering this Plan shall be
borne by the Company.  The captions and section  numbers  appearing in this Plan
are  inserted  only as a  matter  of  convenience.  They do not  define,  limit,
construe or describe the scope or intent of the provisions of this Plan.

          15.  Termination of This Plan. This Plan shall terminate on January 1,
2006,  and  thereafter  no Stock  Options or  Restricted  Stock or SARs shall be
granted  hereunder.  All  Stock  options  and  SARs  outstanding  at the time of
termination  of this Plan shall  continue in full force and effect  according to
their terms and the terms and conditions of this Plan.

          IN WITNESS WHEREOF,  the Company,  by order of its Board of Directors,
has caused the undersigned,  duly authorized officers to execute this Plan as of
the day and year first above written.

                                                  XYBERNAUT CORPORATION

                                            By:
                                                 ------------------------------


                                      -21-

                                                                    EXHIBIT 99.2

                            1997 STOCK INCENTIVE PLAN

                                       OF

                              XYBERNAUT CORPORATION

          1. PURPOSES OF THE PLAN. This stock incentive plan (the "Plan") is
designed to provide an incentive to key employees (including directors and
officers who are key employees) and to consultants and directors who are not
employees of XYBERNAUT CORPORATION, a Delaware corporation (the "Company"), or
any of its Subsidiaries (as defined in Paragraph 18), and to offer an additional
inducement in obtaining the services of such persons. The Plan provides for the
grant of "incentive stock options" ("ISOs") within the meaning of Section 422 of
the Internal Revenue Code of 1986, as amended (the "Code"), nonqualified stock
options which do not qualify as ISOs ("NQSOs"), stock appreciation rights
("SARs") and stock of the Company which may be subject to contingencies or
restrictions (collectively, "Awards"). The Company makes no representation or
warranty, express or implied, as to the qualification of any option as an
"incentive stock option" under the Code.

          2. STOCK SUBJECT TO THE PLAN. Subject to the provisions of Paragraph
11, the aggregate number of shares of Common Stock, $.01 par value per share, of
the Company ("Common Stock") for which Awards may be granted under the Plan
shall not exceed 1,650,000. Such shares of Common Stock may, in the discretion
of the Board of Directors of the Company (the "Board of Directors"), consist
either in whole or in part of authorized but unissued shares of Common Stock or
shares of Common Stock held in the treasury of the Company. Subject to the
provisions of Paragraph 12, any shares of Common Stock subject to an option or
SAR which for any reason expires, is canceled or is terminated unexercised or
which ceases for any reason to be exercisable or a restricted stock Award which
for any reason is forfeited, shall again become available for the granting of
Awards under the Plan. The Company shall at all times during the term of the
Plan reserve and keep available such number of shares of Common Stock as will be
sufficient to satisfy the requirements of the Plan.

          3. ADMINISTRATION OF THE PLAN. The Plan shall be administered by the
Board of Directors or a committee of the Board of Directors consisting of not
less than two directors, each of whom shall be a "non-employee director" within
the meaning of Rule 16b-3 (as defined in Paragraph 18) (collectively, the
"Committee"). Unless otherwise provided in the By-laws of the Company or by
resolution of the Board of Directors, a majority of the members of the Committee
shall constitute a quorum, and the acts of a majority of the members present at
any meeting at which a quorum is present, and any acts approved in writing by
all members without a meeting, shall be the acts of the Committee.


                                      B-1
<PAGE>


          Subject to the express provisions of the Plan, the Committee shall
have the authority, in its sole discretion, to determine: the key employees,
consultants and directors who shall be granted Awards; the type of Award to be
granted; the times when an Award shall be granted; the number of shares of
Common Stock to be subject to each Award; the term of each option and SAR; the
date each option and SAR shall become exercisable; whether an option or SAR
shall be exercisable in whole or in installments and, if in installments, the
number of shares of Common Stock to be subject to each installment, whether the
installments shall be cumulative, the date each installment shall become
exercisable and the term of each installment; whether to accelerate the date of
exercise of any option or SAR or installment thereof; whether shares of Common
Stock may be issued upon the exercise of an option as partly paid and, if so,
the dates when future installments of the exercise price shall become due and
the amounts of such installments; the exercise price of each option and the base
price of each SAR; the price, if any, to be paid for a share Award; the form of
payment of the exercise price of an option; the form of payment upon exercise of
an SAR; whether to restrict the sale or other disposition of a stock Award or
the shares of Common Stock acquired upon the exercise of an option or SAR and,
if so, to determine whether such contingencies and restrictions have been met
and whether and under what conditions to waive any such contingency or
restriction; whether and under what conditions to subject all or a portion of
the grant or exercise of an option or SAR, the vesting of a stock Award or the
shares acquired pursuant to the exercise of an option or SAR to the fulfillment
of certain contingencies or restrictions as specified in the contract referred
to in Paragraph 10 hereof (the "Contract"), including without limitation,
contingencies or restrictions relating to entering into a covenant not to
compete with the Company, any of its Subsidiaries or a Parent (as defined in
Paragraph 18), to financial objectives for the Company, any of its Subsidiaries
or a Parent, a division of any of the foregoing, a product line or other
category, and/or to the period of continued employment of the Award holder with
the Company, any of its Subsidiaries or a Parent, and to determine whether such
contingencies or restrictions have been met; whether an Award holder is Disabled
(as defined in Paragraph 18); the amount, if any, necessary to satisfy the
obligation of the Company, a Subsidiary or Parent to withhold taxes or other
amounts; the Fair Market Value (as defined in Paragraph 18) of a share of Common
Stock; to construe the respective Contracts and the Plan; with the consent of
the Award holder, to cancel or modify an Award, provided, that the modified
provision is permitted to be included in an Award granted under the Plan on the
date of the modification, and further, provided, that in the case of a
modification (within the meaning of Section 424(h) of the Code) of an ISO, such
Award as modified would be permitted to be granted on the date of such
modification under the terms of the Plan; to prescribe, amend and rescind rules
and regulations relating to the Plan; to approve any provision which under Rule
16b-3 requires the approval of the Board of Directors, a committee of
non-employee directors or the stockholders to be exempt (unless otherwise
specifically provided herein); and to make all other determinations necessary or
advisable for administering the Plan. Any controversy or claim arising out of or
relating to the Plan, any Award granted under the Plan or any Contract shall be
determined unilaterally by the Committee in its sole discretion. The
determinations of the Committee on the matters referred to in this Paragraph 3
shall be conclusive and binding on the parties. No member


                                      B-2
<PAGE>

or former member of the Committee shall be liable for any action, failure to act
or determination made in good faith with respect to the Plan or any Award or
Contract hereunder.

          4. OPTIONS

             (a) GRANT. The Committee may from time to time, consistent with the
purposes of the Plan, grant options to such key employees (including officers
and directors who are key employees) of, and consultants to, the Company or any
of its Subsidiaries, and such Outside Directors, as the Committee may determine,
in its sole discretion. Such options granted shall cover such number of shares
of Common Stock as the Committee may determine, in its sole discretion, as set
forth in the applicable Contract; provided, however, that the maximum number of
shares subject to options or SARs that may be granted to any employee during any
calendar year under the Plan (the "162(m) Maximum") shall be 350,000 shares; and
further, provided, that the aggregate Fair Market Value (determined at the time
the option is granted) of the shares of Common Stock for which any eligible
employee may be granted ISOs under the Plan or any other plan of the Company, of
any of its Subsidiaries or of a Parent, which are exercisable for the first time
by such optionee during any calendar year shall not exceed $100,000. Such ISO
limitation shall be applied by taking ISOs into account in the order in which
they were granted. Any option granted in excess of such ISO limitation amount
shall be treated as a NQSO to the extent of such excess.

             (b) EXERCISE PRICE. The exercise price of the shares of Common
Stock under each option shall be determined by the Committee, in its sole
discretion, as set forth in the applicable Contract; provided, however, that the
exercise price per share of an ISO shall not be less than the Fair Market Value
of a share of Common Stock on the date of grant; and further, provided, that if,
at the time an ISO is granted, the optionee owns (or is deemed to own under
Section 424(d) of the Code) stock possessing more than 10% of the total combined
voting power of all classes of stock of the Company, of any of its Subsidiaries
or of a Parent, the exercise price per share of such ISO shall not be less than
110% of the Fair Market Value of a share of Common Stock on the date of grant.

             (c) TERM. The term of each option granted pursuant to the Plan
shall be determined by the Committee, in its sole discretion, as set forth in
the applicable Contract; provided, however, that the term of each ISO shall not
exceed 10 years from the date of grant thereof; and further, provided, that if,
at the time an ISO is granted, the optionee owns (or is deemed to own under
Section 424(d) of the Code) stock possessing more than 10% of the total combined
voting power of all classes of stock of the Company, of any of its Subsidiaries
or of a Parent, the term of the ISO shall not exceed five years from the date of
grant. Options shall be subject to earlier termination as hereinafter provided.

             (d) EXERCISE. An option (or any part or installment thereof), to
the extent then exercisable, shall be exercised by giving written notice to the
Company at its then


                                      B-3
<PAGE>

principal office stating which option is being exercised, specifying the number
of shares of Common Stock as to which such option is being exercised and
accompanied by payment in full of the aggregate exercise price therefor (or the
amount due upon exercise if the Contract permits installment payments) (a) in
cash or by certified check or (b) if the applicable Contract permits, with
previously acquired shares of Common Stock having an aggregate Fair Market Value
on the date of exercise equal to the aggregate exercise price of all options
being exercised, or with any combination of cash, certified check or shares of
Common Stock having such value. The Company shall not be required to issue any
shares of Common Stock pursuant to any such option until all required payments,
including any required withholding, have been made.

          The Committee may, in its sole discretion, permit payment of all or a
portion of the exercise price of an option by delivery by the optionee of a
properly executed notice, together with a copy of his irrevocable instructions
to a broker acceptable to the Committee to deliver promptly to the Company the
amount of sale or loan proceeds sufficient to pay such exercise price. In
connection therewith, the Company may enter into agreements for coordinated
procedures with one or more brokerage firms.

          An optionee entitled to receive Common Stock upon the exercise of an
option shall not have the rights of a stockholder with respect to such shares of
Common Stock until the date of issuance of a stock certificate for such shares
or, in the case of uncertificated shares, until an entry is made on the books of
the Company's transfer agent representing such shares; provided, however, that
until such stock certificate is issued or book entry is made, any optionee using
previously acquired shares of Common Stock in payment of an option exercise
price shall continue to have the rights of a stockholder with respect to such
previously acquired shares.

          In no case may an option be exercised with respect to a fraction of a
share of Common Stock. In no case may a fraction of a share of Common Stock be
purchased or issued under the Plan.

             (e) RELOAD OPTIONS. An optionee who, at a time when he is eligible
to be granted options under the Plan, uses previously acquired shares of Common
Stock to exercise an option granted under the Plan (the "prior option"), shall,
upon such exercise, be automatically granted an option (the "reload option") to
purchase the same number of shares of Common Stock so used (or if there is not a
sufficient number of shares available for grant under the Plan remaining, such
number of shares as are then available). Such reload options shall be of the
same type and have the same terms as the prior option (except to the extent
inconsistent with the terms of the Plan); provided, however, that the exercise
price per share of the reload option shall be equal to the Fair Market Value of
a share of Common Stock on the date of grant of the reload option, and further,
provided, that if the prior option was an ISO and at the time the reload option
is granted, the optionee owns (or is deemed to own under Section 424(d) of the
Code) stock possessing more than 10% of the total combined voting power of all
classes of stock of the Company, of any of its Subsidiaries or of a Parent, the
exercise price per share shall be equal to


                                      B-4
<PAGE>

110% of the Fair Market Value of a share of Common Stock on the date of grant
and the term of such option shall not exceed five years.

          5. STOCK APPRECIATION RIGHTS.

             (a) GRANT. The Committee may from time to time, consistent with the
purposes of the Plan, grant SARs to such key employees (including officers and
directors who are key employees) of, and consultants to, the Company or any of
its Subsidiaries, and such Outside Directors, as the Committee may determine in
its sole discretion. An SAR shall entitle the holder thereof to be paid,
promptly after exercise, in cash, by check or with shares of Common Stock having
an aggregate Fair Market Value on the date of exercise or any combination
thereof, as determined by the Committee, in its sole discretion, an amount equal
to the excess, if any, of the Fair Market Value on the exercise date of the
shares of Common Stock as to which the SAR is exercised over the base price of
such shares. The Contract may (but shall not be required to) provide for such
amount to be multiplied by a performance factor as set forth in the Contract;
provided, however, that such performance factor shall meet the requirements for
"qualified performance-based compensation" within the meaning of Section 162(m)
of the Code.

             (b) BASE PRICE. The base price of the shares of Common Stock
subject to each SAR shall be determined by the Committee in its sole discretion;
provided, however, that the base price per share shall not be less than the Fair
Market Value of a share of Common Stock on the date of grant.

             (c) TERM. The term of each SAR granted pursuant to the Plan shall
be determined by the Committee, in its sole discretion, as set forth in the
applicable Contract; provided, however, that the term of each SAR shall not
exceed 10 years from the date of grant. SARs shall be subject to earlier
termination as provided in the Plan.

             (d) EXERCISE. An SAR (or any part or installment thereof), to the
extent then exercisable, shall be exercised by giving written notice to the
Company at its then principle office stating which SAR is being exercised and
specifying the number of shares of Common Stock as to which such SAR is being
exercised.

          The holder of an SAR who receives shares of Common Stock upon the
exercise of an SAR shall not have the rights of a stockholder with respect to
such shares of Common Stock until the date of issuance of a stock certificate
for such shares or, in the case of uncertificated shares, until an entry is made
on the books of the Company's transfer agent representing such shares.

          In no case may an SAR be exercised with respect to a fraction of a
share of Common Stock.


                                      B-5
<PAGE>

          6. RESTRICTED STOCK. The Committee may from time, consistent with the
purposes of the Plan, grant shares of Common Stock to such key employees
(including officers and directors who are key employees) of, or consultants to,
the Company or any of its Subsidiaries, as the Committee may determine, in its
sole discretion. The grant may cover such number of shares as the Committee may
determine, in its sole discretion, and require the Award holder to pay such
price per share therefor, if any, as the Committee may determine, in its sole
discretion. Such shares may be subject to such contingencies and restrictions as
the Committee may determine, as set forth in the Contract. Upon the issuance of
the stock certificate for a share Award, or in the case of uncertificated
shares, the entry on the books of the Company's transfer agent representing such
shares, notwithstanding any contingencies or restrictions to which the shares
are subject, the Award holder shall be considered to be the record owner of the
shares, and subject to the contingencies and restrictions set forth in the
Award, shall have all rights of a stockholder of record with respect to such
shares, including the right to vote and to receive distributions. Upon the
occurrence of any such contingency or restriction, the Award holder may be
required to forfeit all or a portion of such shares back to the Company. The
shares shall vest in the Award holder when all of the restrictions and
contingencies lapse. Accordingly, the Committee may require that such shares be
held by the Company, together with a stock power duly endorsed in blank by the
Award holder, until the shares vest in the Award holder.

          7. TERMINATION OF RELATIONSHIP. Except as may otherwise be expressly
provided in the applicable Contract, if an Award holder's relationship with the
Company, its Subsidiaries and Parent as an employee or a consultant has
terminated for any reason (other than as a result of his death or Disability),
the Award holder may exercise the options and SARs granted to him as an employee
of, or consultant to, the Company or any of its Subsidiaries, to the extent
exercisable on the date of such termination, at any time within three months
after the date of termination, but not thereafter and in no event after the date
the Award would otherwise have expired; provided, however, that if such
relationship is terminated either (a) for Cause (as defined in Paragraph 18), or
(b) without the consent of the Company, such option shall terminate immediately.

          For the purposes of the Plan, an employment relationship shall be
deemed to exist between an individual and the Company, any of its Subsidiaries
or a Parent if, at the time of the determination, the individual was an employee
of such corporation for purposes of Section 422(a) of the Code. As a result, an
individual on military, sick leave or other bona fide leave of absence shall
continue to be considered an employee for purposes of the Plan during such leave
if the period of the leave does not exceed 90 days, or, if longer, so long as
the individual's right to reemployment with the Company, any of its Subsidiaries
or a Parent is guaranteed either by statute or by contract. If the period of
leave exceeds 90 days and the individual's right to reemployment is not
guaranteed by statute or by contract, the employment relationship shall be
deemed to have terminated on the 91st day of such leave.


                                      B-6
<PAGE>


          Except as may otherwise be expressly provided in the applicable
Contract, options and SARs granted under the Plan shall not be affected by any
change in the status of the Award holder so long as he continues to be an
employee of, or a consultant to, the Company, or any of its Subsidiaries or a
Parent (regardless of having changed from one to the other or having been
transferred from one corporation to another).

          Except as may otherwise be expressly provided in the applicable
Contract, if an Award holder's relationship with the Company as an Outside
Director ceases for any reason (other than as a result of his death or
Disability) then options and SARs granted to such holder as an Outside Director
may be exercised, to the extent exercisable on the date of such termination, at
any time within three months after the date of termination, but not thereafter
and in no event after the date the Award would otherwise have expired; provided,
however, that if such relationship is terminated for Cause, such Award shall
terminate immediately. An Award granted to an Outside Director, however, shall
not be affected by the Award holder becoming an employee of, or consultant to,
the Company, any of its Subsidiaries or a Parent.

          Except as may otherwise be expressly provided in the Contract, upon
the termination of the relationship of an Award holder as an employee of, or
consultant to, the Company, and its Subsidiaries and Parent, or as an Outside
Director, for any reason (including his death or Disability), the share Award
shall cease any further vesting and the unvested portion of such Award as of the
date of such termination shall be forfeited to the Company for no consideration.

          Nothing in the Plan or in any Award granted under the Plan shall
confer on any Award holder any right to continue in the employ of, or as a
consultant to, the Company, any of its Subsidiaries or a Parent, or as a
director of the Company, or interfere in any way with any right of the Company,
any of its Subsidiaries or a Parent to terminate the Award holder's relationship
at any time for any reason whatsoever without liability to the Company, any of
its Subsidiaries or a Parent.

          8. DEATH OR DISABILITY. Except as may otherwise be expressly provided
in the applicable Contract, if an Award holder dies (a) while he is an employee
of, or consultant to, the Company, any of its Subsidiaries or a Parent, (b)
within three months after the termination of such relationship (unless such
termination was for Cause or without the consent of the Company) or (c) within
one year following the termination of such relationship by reason of his
Disability, the options and SARs that were granted to him as an employee of, or
consultant to, the Company or any of its Subsidiaries, may be exercised, to the
extent exercisable on the date of his death, by his Legal Representative (as
defined in Paragraph 18) at any time within one year after death, but not
thereafter and in no event after the date the option would otherwise have
expired.


                                      B-7
<PAGE>

          Except as may otherwise be expressly provided in the applicable
Contract, if an Award holder's relationship as an employee of, or consultant to,
the Company, any of its Subsidiaries or a Parent has terminated by reason of his
Disability, the options and SARs that were granted to him as an employee of, or
consultant to the Company or any of its Subsidiaries may be exercised, to the
extent exercisable upon the effective date of such termination, at any time
within one year after such date, but not thereafter and in no event after the
date the option would otherwise have expired.

          Except as may otherwise be expressly provided in the applicable
Contract, if an Award holder's relationship as an Outside Director terminates as
a result of his death or Disability, the options and SARs granted to him as an
Outside Director may be exercised, to the extent exercisable on the date of such
termination, at any time within one year after the date of termination, but not
thereafter and in no event after the date the Award would otherwise have
expired. In the case of the death of the Award holder, the Award may be
exercised by his Legal Representative.

          9. COMPLIANCE WITH SECURITIES LAWS. It is a condition to the issuance
of any share Award and exercise of any option or SAR that either (a) a
Registration Statement under the Securities Act of 1933, as amended (the
"Securities Act"), with respect to the shares of Common Stock to be issued upon
such grant or exercise shall be effective and current at the time of exercise,
or (b) there is an exemption from registration under the Securities Act for the
issuance of the shares of Common Stock upon such exercise. Nothing herein shall
be construed as requiring the Company to register shares subject to any Award
under the Securities Act or to keep any Registration Statement effective or
current.

          The Committee may require, in its sole discretion, as a condition to
the receipt of an Award or the exercise of any option or SAR that the Award
holder execute and deliver to the Company his representations and warranties, in
form, substance and scope satisfactory to the Committee, which the Committee
determines are necessary or convenient to facilitate the perfection of an
exemption from the registration requirements of the Securities Act, applicable
state securities laws or other legal requirement, including, without limitation,
that (a) the shares of Common Stock to be received under the Award or issued
upon the exercise of the option or SAR are being acquired by the Award holder
for his own account, for investment only and not with a view to the resale or
distribution thereof, and (b) any subsequent resale or distribution of shares of
Common Stock by such Award holder will be made only pursuant to (i) a
Registration Statement under the Securities Act which is effective and current
with respect to the shares of Common Stock being sold, or (ii) a specific
exemption from the registration requirements of the Securities Act, but in
claiming such exemption, the Award holder shall prior to any offer of sale or
sale of such shares of Common Stock provide the Company with a favorable written
opinion of counsel satisfactory to the Company, in form, substance and scope
satisfactory to the Company, as to the applicability of such exemption to the
proposed sale or distribution.


                                      B-8
<PAGE>


          In addition, if at any time the Committee shall determine, in its sole
discretion, that the listing or qualification of the shares of Common Stock
subject to any Award or option on any securities exchange, Nasdaq or under any
applicable law, or the consent or approval of any governmental agency or
regulatory body, is necessary or desirable as a condition to, or in connection
with, the granting of an Award or the issuing of shares of Common Stock
thereunder, such Award may not be granted and such option or SAR may not be
exercised in whole or in part unless such listing, qualification, consent or
approval shall have been effected or obtained free of any conditions not
acceptable to the Committee.

          10. AWARD CONTRACTS. Each Award shall be evidenced by an appropriate
Contract which shall be duly executed by the Company and the Award holder, and
shall contain such terms, provisions and conditions not inconsistent herewith as
may be determined by the Committee. The terms of each Award and Contract need
not be identical.

          11. ADJUSTMENTS UPON CHANGES IN COMMON STOCK. Notwithstanding any
other provision of the Plan, in the event of a stock dividend, recapitalization,
merger in which the Company is the surviving corporation, spin-off, split-up,
combination or exchange of shares or the like which results in a change in the
number or kind of shares of Common Stock which is outstanding immediately prior
to such event, the aggregate number and kind of shares subject to the Plan, the
aggregate number and kind of shares subject to each outstanding Award, the
exercise price of each option, the base price of each SAR, any contingencies and
restrictions based on the number or kind of shares, and the 162(m) Maximum shall
be appropriately adjusted by the Board of Directors, whose determination shall
be conclusive and binding on all parties. Such adjustment may provide for the
elimination of fractional shares which might otherwise be subject to Awards
without payment therefor.

          In the event of (a) the liquidation or dissolution of the Company, (b)
a merger in which the Company is not the surviving corporation or a
consolidation, or (c) any transaction (or series of related transactions) in
which (i) more than 50% of the outstanding Common Stock is transferred or
exchanged for other consideration or (ii) shares of Common Stock in excess of
the number of shares of Common Stock outstanding immediately preceding the
transaction are issued (other than to stockholder of the Company with respect to
their shares of stock in the Company, any outstanding options, SARs or unvested
stock shall terminate upon the earliest of any such event, unless other
provision is made therefor in the transaction.

          12. AMENDMENTS AND TERMINATION OF THE PLAN. The Plan was adopted by
the Board of Directors on April 10, 1997. No ISO may be granted under the Plan
after April 9, 2007. The Board of Directors, without further approval of the
Company's stockholders, may at any time suspend or terminate the Plan, in whole
or in part, or amend it from time to time in such respects as it may deem
advisable, including, without limitation, in order that ISOs granted hereunder
meet the requirements for "incentive stock options" under the Code, to comply
with the provisions of Rule 16b-3, Section 162(m) of the Code, or any change in
applicable law,


                                      B-9
<PAGE>

regulations, rulings or interpretations of any governmental agency or regulatory
body; provided, however, that no amendment shall be effective without the
requisite prior or subsequent stockholder approval which would (a) except as
contemplated in Paragraph 11, increase the maximum number of shares of Common
Stock for which Awards may be granted under the Plan or the 162(m) Maximum, (b)
change the eligibility requirements to receive Awards hereunder, or (c) make any
change for which applicable law, regulation, ruling or interpretation by the
applicable governmental agency or regulatory authority requires stockholder
approval. No termination, suspension or amendment of the Plan shall adversely
affect the rights of any Award holder under an Award without his prior consent.
The power of the Committee to construe and administer any Awards granted under
the Plan prior to the termination or suspension of the Plan nevertheless shall
continue after such termination or during such suspension.

          13. NON-TRANSFERABILITY. No option or SAR granted under the Plan shall
be transferable otherwise than by will or the laws of descent and distribution,
and options and SARs may be exercised, during the lifetime of the Award holder,
only by him or his Legal Representatives. Except as may otherwise be expressly
provided in the Contract, a stock Award, to the extent not vested, shall not be
transferable otherwise than by will or the laws of descent and distribution.
Except to the extent provided above, Awards may not be assigned, transferred,
pledged, hypothecated or disposed of in any way (whether by operation of law or
otherwise) and shall not be subject to execution, attachment or similar process,
and any such attempted assignment, transfer, pledge, hypothecation or
disposition shall be null and void ab initio and of no force or effect.

          14. WITHHOLDING TAXES. The Company, a Subsidiary or Parent may
withhold (a) cash or (b) with the consent of the Committee, shares of Common
Stock to be issued under a stock Award or upon exercise of an option or SAR
having an aggregate Fair Market Value on the relevant date, or a combination of
cash and shares having such value, in an amount equal to the amount which the
Committee determines is necessary to satisfy the obligation of the Company, any
of its Subsidiaries or a Parent to withhold federal, state and local taxes or
other amounts incurred by reason of the grant, vesting, exercise or disposition
of an Award, or the disposition of the underlying shares of Common Stock.
Alternatively, the Company may require the holder to pay to the Company such
amount, in cash, promptly upon demand.

          15. LEGENDS; PAYMENT OF EXPENSES. The Company may endorse such legend
or legends upon the certificates for shares of Common Stock issued under a stock
Award or upon exercise of an option or SAR under the Plan and may issue such
"stop transfer" instructions to its transfer agent in respect of such shares as
it determines, in its discretion, to be necessary or appropriate to (a) prevent
a violation of, or to perfect an exemption from, the registration requirements
of the Securities Act and any applicable state securities laws, (b) implement
the provisions of the Plan or any agreement between the Company and the Award
holder with respect to such shares of Common Stock, or (c) permit the Company to
determine the


                                      B-10
<PAGE>

occurrence of a "disqualifying disposition," as described in Section 421(b) of
the Code, of the shares of Common Stock issued or transferred upon the exercise
of an ISO granted under the Plan.

          The Company shall pay all issuance taxes with respect to the issuance
of shares of Common Stock under a stock Award or upon the exercise of an option
or SAR granted under the Plan, as well as all fees and expenses incurred by the
Company in connection with such issuance.

          16. USE OF PROCEEDS. The cash proceeds received upon the exercise of
an option, or grant of a stock Award under the Plan shall be added to the
general funds of the Company and used for such corporate purposes as the Board
of Directors may determine.

          17. SUBSTITUTIONS AND ASSUMPTIONS OF AWARDS OF CERTAIN CONSTITUENT
CORPORATIONS. Anything in this Plan to the contrary notwithstanding, the Board
of Directors may, without further approval by the stockholders, substitute new
Awards for prior options, SARs or restricted stock of a Constituent Corporation
(as defined in Paragraph 18) or assume the prior options or restricted stock of
such Constituent Corporation.

          18. DEFINITIONS. For purposes of the Plan, the following terms shall
be defined as set forth below:

             (a) "Cause" shall mean (i) in the case of an employee or
consultant, if there is a written employment or consulting agreement between the
Award holder and the Company, any of its Subsidiaries or a Parent which defines
termination of such relationship for cause, cause as defined in such agreement,
and (ii) in all other cases, cause as defined by applicable state law.

             (b) "Constituent Corporation" shall mean any corporation which
engages with the Company, any of its Subsidiaries or a Parent in a transaction
to which Section 424(a) of the Code applies (or would apply if the option
assumed or substituted were an ISO), or any Subsidiary or Parent of such
corporation.

             (c) "Disability" shall mean a permanent and total disability within
the meaning of Section 22(e)(3) of the Code.

             (d) "Exchange Act" means the Securities Exchange Act of 1934, as
amended.

             (e) "Fair Market Value" of a share of Common Stock on any day shall
mean (i) if the principal market for the Common Stock is a national securities
exchange, the average of the highest and lowest sales prices per share of Common
Stock on such day as reported


                                      B-11
<PAGE>


by such exchange or on a composite tape reflecting transactions on such
exchange, (ii) if the principal market for the Common Stock is not a national
securities exchange and the Common Stock is quoted on Nasdaq, and (A) if actual
sales price information is available with respect to the Common Stock, the
average of the highest and lowest sales prices per share of Common Stock on such
day on Nasdaq, or (B) if such information is not available, the average of the
highest bid and lowest asked prices per share of Common Stock on such day on
Nasdaq, or (iii) if the principal market for the Common Stock is not a national
securities exchange and the Common Stock is not quoted on Nasdaq, the average of
the highest bid and lowest asked prices per share of Common Stock on such day as
reported on the OTC Bulletin Board Service or by National Quotation Bureau,
Incorporated or a comparable service; provided, however, that if clauses (i),
(ii) and (iii) of this subparagraph are all inapplicable, or if no trades have
been made or no quotes are available for such day, the Fair Market Value of a
share of Common Stock shall be determined by the Board of Directors by any
method consistent with applicable regulations adopted by the Treasury Department
relating to stock options.

             (f) "Legal Representative" shall mean the executor, administrator
or other person who at the time is entitled by law to exercise the rights of a
deceased or incapacitated optionee with respect to an option granted under the
Plan.

             (g) "Nasdaq" shall mean the Nasdaq Stock Market.

             (h) "Outside Director" shall mean a person who is a director of the
Company, but on the date of grant is not an employee of, or consultant to, the
Company, any of its Subsidiaries or a Parent.

             (i) "Parent" shall have the same definition as "parent corporation"
in Section 424(e) of the Code.

             (j) "Rule 16b-3" shall mean Rule 16b-3 promulgated under the
Exchange Act, as the same may be in effect and interpreted from time to time.

             (k) "Subsidiary" shall have the same definition as "subsidiary
corporation" in Section 424(f) of the Code.

          19. GOVERNING LAW; CONSTRUCTION. The Plan, the Awards and Contracts
hereunder and all related matters shall be governed by, and construed in
accordance with, the laws of the State of Delaware, without regard to conflict
of law provisions that would defer to the substantive laws of another
jurisdiction.

          Neither the Plan nor any Contract shall be construed or interpreted
with any presumption against the Company by reason of the Company causing the
Plan or Contract to be drafted. Whenever from the context it appears
appropriate, any term stated in either the singular or plural shall include the
singular


                                      B-12
<PAGE>

and plural, and any term stated in the masculine, feminine or neuter gender
shall include the masculine, feminine and neuter.

          20. PARTIAL INVALIDITY. The invalidity, illegality or unenforceability
of any provision in the Plan, any Award or Contract shall not affect the
validity, legality or enforceability of any other provision, all of which shall
be valid, legal and enforceable to the fullest extent permitted by applicable
law.

          21. STOCKHOLDER APPROVAL. The Plan shall be subject to approval by a
majority of the votes present in person or by proxy and entitled to vote hereon
at the next duly held meeting of the Company's stockholders at which a quorum is
present. No Award granted hereunder may vest or be exercised prior to such
approval; provided, however, that the date of grant of any Award shall be
determined as if the Plan had not been subject to such approval. Notwithstanding
the foregoing, if the Plan is not approved by a vote of the stockholders of the
Company on or before April 9, 1998, the Plan and any Awards granted hereunder
shall terminate.


                                      B-13


                                                                    EXHIBIT 99.3

                            1999 STOCK INCENTIVE PLAN

                                       OF

                              XYBERNAUT CORPORATION

          1. PURPOSES OF THE PLAN. This stock incentive plan (the "Plan") is
designed to provide an incentive to key employees (including directors and
officers who are key employees) and to consultants and directors who are not
employees of XYBERNAUT CORPORATION, a Delaware corporation (the "Company"), or
any of its Subsidiaries (as defined in Paragraph 18), and to offer an additional
inducement in obtaining the services of such persons. The Plan provides for the
grant of "incentive stock options" ("ISOs") within the meaning of Section 422 of
the Internal Revenue Code of 1986, as amended (the "Code"), nonqualified stock
options which do not qualify as ISOs ("NQSOs"), stock appreciation rights
("SARs") and stock of the Company which may be subject to contingencies or
restrictions (collectively, "Awards"). The Company makes no representation or
warranty, express or implied, as to the qualification of any option as an
"incentive stock option" under the Code.

          2. STOCK SUBJECT TO THE PLAN. Subject to the provisions of Paragraph
11, the aggregate number of shares of Common Stock, $.01 par value per share, of
the Company ("Common Stock") for which Awards may be granted under the Plan
shall not exceed 3,000,000. Such shares of Common Stock may, in the discretion
of the Board of Directors of the Company (the "Board of Directors"), consist
either in whole or in part of authorized but unissued shares of Common Stock or
shares of Common Stock held in the treasury of the Company. Subject to the
provisions of Paragraph 12, any shares of Common Stock subject to an option or
SAR which for any reason expires, is canceled or is terminated unexercised or
which ceases for any reason to be exercisable or a restricted stock Award which
for any reason is forfeited, shall again become available for the granting of
Awards under the Plan. The Company shall at all times during the term of the
Plan reserve and keep available such number of shares of Common Stock as will be
sufficient to satisfy the requirements of the Plan.

          3. ADMINISTRATION OF THE PLAN. The Plan shall be administered by the
Board of Directors or a committee of the Board of Directors consisting of not
less than two directors, each of whom shall be a "non-employee director" within
the meaning of Rule 16b-3 (as defined in Paragraph 18) (collectively, the
"Committee"). Unless otherwise provided in the By-laws of the Company or by
resolution of the Board of Directors, a majority of the members of the Committee
shall constitute a quorum, and the acts of a majority of the members present at
any meeting at which a quorum is present, and any acts approved in writing by
all members without a meeting, shall be the acts of the Committee.

          Subject to the express provisions of the Plan, the Committee shall
have the authority, in its sole discretion, to determine: the key employees,
consultants and directors who


                                      B-1
<PAGE>

shall be granted Awards; the type of Award to be granted; the times when an
Award shall be granted; the number of shares of Common Stock to be subject to
each Award; the term of each option and SAR; the date each option and SAR shall
become exercisable; whether an option or SAR shall be exercisable in whole or in
installments and, if in installments, the number of shares of Common Stock to be
subject to each installment, whether the installments shall be cumulative, the
date each installment shall become exercisable and the term of each installment;
whether to accelerate the date of exercise of any option or SAR or installment
thereof; whether shares of Common Stock may be issued upon the exercise of an
option as partly paid and, if so, the dates when future installments of the
exercise price shall become due and the amounts of such installments; the
exercise price of each option and the base price of each SAR; the price, if any,
to be paid for a share Award; the form of payment of the exercise price of an
option; the form of payment upon exercise of an SAR; whether to restrict the
sale or other disposition of a stock Award or the shares of Common Stock
acquired upon the exercise of an option or SAR and, if so, to determine whether
such contingencies and restrictions have been met and whether and under what
conditions to waive any such contingency or restriction; whether and under what
conditions to subject all or a portion of the grant or exercise of an option or
SAR, the vesting of a stock Award or the shares acquired pursuant to the
exercise of an option or SAR to the fulfillment of certain contingencies or
restrictions as specified in the contract referred to in Paragraph 10 hereof
(the "Contract"), including without limitation, contingencies or restrictions
relating to entering into a covenant not to compete with the Company, any of its
Subsidiaries or a Parent (as defined in Paragraph 18), to financial objectives
for the Company, any of its Subsidiaries or a Parent, a division of any of the
foregoing, a product line or other category, and/or to the period of continued
employment of the Award holder with the Company, any of its Subsidiaries or a
Parent, and to determine whether such contingencies or restrictions have been
met; whether an Award holder is Disabled (as defined in Paragraph 18); the
amount, if any, necessary to satisfy the obligation of the Company, a Subsidiary
or Parent to withhold taxes or other amounts; the Fair Market Value (as defined
in Paragraph 18) of a share of Common Stock; to construe the respective
Contracts and the Plan; with the consent of the Award holder, to cancel or
modify an Award, provided, that the modified provision is permitted to be
included in an Award granted under the Plan on the date of the modification, and
further, provided, that in the case of a modification (within the meaning of
Section 424(h) of the Code) of an ISO, such Award as modified would be permitted
to be granted on the date of such modification under the terms of the Plan; to
prescribe, amend and rescind rules and regulations relating to the Plan; to
approve any provision which under Rule 16b-3 requires the approval of the Board
of Directors, a committee of non-employee directors or the stockholders to be
exempt (unless otherwise specifically provided herein); and to make all other
determinations necessary or advisable for administering the Plan. Any
controversy or claim arising out of or relating to the Plan, any Award granted
under the Plan or any Contract shall be determined unilaterally by the Committee
in its sole discretion. The determinations of the Committee on the matters
referred to in this Paragraph 3 shall be conclusive and binding on the parties.
No member or former member of the Committee shall be liable for any action,
failure to act or determination made in good faith with respect to the Plan or
any Award or Contract hereunder.

          4. OPTIONS

                                      B-2
<PAGE>


             (a) GRANT. The Committee may from time to time, consistent with the
purposes of the Plan, grant options to such key employees (including officers
and directors who are key employees) of, and consultants to, the Company or any
of its Subsidiaries, and such Outside Directors, as the Committee may determine,
in its sole discretion. Such options granted shall cover such number of shares
of Common Stock as the Committee may determine, in its sole discretion, as set
forth in the applicable Contract; provided, however, that the maximum number of
shares subject to options or SARs that may be granted to any employee during any
calendar year under the Plan (the "162(m) Maximum") shall be 350,000 shares; and
further, provided, that the aggregate Fair Market Value (determined at the time
the option is granted) of the shares of Common Stock for which any eligible
employee may be granted ISOs under the Plan or any other plan of the Company, of
any of its Subsidiaries or of a Parent, which are exercisable for the first time
by such optionee during any calendar year shall not exceed $100,000. Such ISO
limitation shall be applied by taking ISOs into account in the order in which
they were granted. Any option granted in excess of such ISO limitation amount
shall be treated as a NQSO to the extent of such excess.

             (b) EXERCISE PRICE. The exercise price of the shares of Common
Stock under each option shall be determined by the Committee, in its sole
discretion, as set forth in the applicable Contract; provided, however, that the
exercise price per share of an ISO shall not be less than the Fair Market Value
of a share of Common Stock on the date of grant; and further, provided, that if,
at the time an ISO is granted, the optionee owns (or is deemed to own under
Section 424(d) of the Code) stock possessing more than 10% of the total combined
voting power of all classes of stock of the Company, of any of its Subsidiaries
or of a Parent, the exercise price per share of such ISO shall not be less than
110% of the Fair Market Value of a share of Common Stock on the date of grant.

             (c) TERM. The term of each option granted pursuant to the Plan
shall be determined by the Committee, in its sole discretion, as set forth in
the applicable Contract; provided, however, that the term of each ISO shall not
exceed 10 years from the date of grant thereof; and further, provided, that if,
at the time an ISO is granted, the optionee owns (or is deemed to own under
Section 424(d) of the Code) stock possessing more than 10% of the total combined
voting power of all classes of stock of the Company, of any of its Subsidiaries
or of a Parent, the term of the ISO shall not exceed five years from the date of
grant. Options shall be subject to earlier termination as hereinafter provided.

             (d) EXERCISE. An option (or any part or installment thereof), to
the extent then exercisable, shall be exercised by giving written notice to the
Company at its then principal office stating which option is being exercised,
specifying the number of shares of Common Stock as to which such option is being
exercised and accompanied by payment in full of the aggregate exercise price
therefor (or the amount due upon exercise if the Contract permits installment
payments) (a) in cash or by certified check or (b) if the applicable Contract
permits, with previously acquired shares of Common Stock having an aggregate
Fair Market Value on the date of exercise equal to the aggregate exercise price
of all options being exercised, or with any combination of cash, certified check
or shares of Common Stock having such value. The


                                      B-3
<PAGE>

Company shall not be required to issue any shares of Common Stock pursuant to
any such option until all required payments, including any required withholding,
have been made.

          The Committee may, in its sole discretion, permit payment of all or a
portion of the exercise price of an option by delivery by the optionee of a
properly executed notice, together with a copy of his irrevocable instructions
to a broker acceptable to the Committee to deliver promptly to the Company the
amount of sale or loan proceeds sufficient to pay such exercise price. In
connection therewith, the Company may enter into agreements for coordinated
procedures with one or more brokerage firms.

          An optionee entitled to receive Common Stock upon the exercise of an
option shall not have the rights of a stockholder with respect to such shares of
Common Stock until the date of issuance of a stock certificate for such shares
or, in the case of uncertificated shares, until an entry is made on the books of
the Company's transfer agent representing such shares; provided, however, that
until such stock certificate is issued or book entry is made, any optionee using
previously acquired shares of Common Stock in payment of an option exercise
price shall continue to have the rights of a stockholder with respect to such
previously acquired shares.

          In no case may an option be exercised with respect to a fraction of a
share of Common Stock. In no case may a fraction of a share of Common Stock be
purchased or issued under the Plan.

             (e) RELOAD OPTIONS. An optionee who, at a time when he is eligible
to be granted options under the Plan, uses previously acquired shares of Common
Stock to exercise an option granted under the Plan (the "prior option"), shall,
upon such exercise, be automatically granted an option (the "reload option") to
purchase the same number of shares of Common Stock so used (or if there is not a
sufficient number of shares available for grant under the Plan remaining, such
number of shares as are then available). Such reload options shall be of the
same type and have the same terms as the prior option (except to the extent
inconsistent with the terms of the Plan); provided, however, that the exercise
price per share of the reload option shall be equal to the Fair Market Value of
a share of Common Stock on the date of grant of the reload option, and further,
provided, that if the prior option was an ISO and at the time the reload option
is granted, the optionee owns (or is deemed to own under Section 424(d) of the
Code) stock possessing more than 10% of the total combined voting power of all
classes of stock of the Company, of any of its Subsidiaries or of a Parent, the
exercise price per share shall be equal to 110% of the Fair Market Value of a
share of Common Stock on the date of grant and the term of such option shall not
exceed five years.

          5. STOCK APPRECIATION RIGHTS.

             (a) GRANT. The Committee may from time to time, consistent with the
purposes of the Plan, grant SARs to such key employees (including officers and
directors who are key employees) of, and consultants to, the Company or any of
its Subsidiaries, and such Outside Directors, as the Committee may determine in
its sole discretion. An SAR shall entitle


                                      B-4
<PAGE>

the holder thereof to be paid, promptly after exercise, in cash, by check or
with shares of Common Stock having an aggregate Fair Market Value on the date of
exercise or any combination thereof, as determined by the Committee, in its sole
discretion, an amount equal to the excess, if any, of the Fair Market Value on
the exercise date of the shares of Common Stock as to which the SAR is exercised
over the base price of such shares. The Contract may (but shall not be required
to) provide for such amount to be multiplied by a performance factor as set
forth in the Contract; provided, however, that such performance factor shall
meet the requirements for "qualified performance-based compensation" within the
meaning of Section 162(m) of the Code.

             (b) BASE PRICE. The base price of the shares of Common Stock
subject to each SAR shall be determined by the Committee in its sole discretion;
provided, however, that the base price per share shall not be less than the Fair
Market Value of a share of Common Stock on the date of grant.

             (c) TERM. The term of each SAR granted pursuant to the Plan shall
be determined by the Committee, in its sole discretion, as set forth in the
applicable Contract; provided, however, that the term of each SAR shall not
exceed 10 years from the date of grant. SARs shall be subject to earlier
termination as provided in the Plan.

             (d) EXERCISE. An SAR (or any part or installment thereof), to the
extent then exercisable, shall be exercised by giving written notice to the
Company at its then principle office stating which SAR is being exercised and
specifying the number of shares of Common Stock as to which such SAR is being
exercised.

          The holder of an SAR who receives shares of Common Stock upon the
exercise of an SAR shall not have the rights of a stockholder with respect to
such shares of Common Stock until the date of issuance of a stock certificate
for such shares or, in the case of uncertificated shares, until an entry is made
on the books of the Company's transfer agent representing such shares.

          In no case may an SAR be exercised with respect to a fraction of a
share of Common Stock.

          6. RESTRICTED STOCK. The Committee may from time, consistent with the
purposes of the Plan, grant shares of Common Stock to such key employees
(including officers and directors who are key employees) of, or consultants to,
the Company or any of its Subsidiaries, as the Committee may determine, in its
sole discretion. The grant may cover such number of shares as the Committee may
determine, in its sole discretion, and require the Award holder to pay such
price per share therefor, if any, as the Committee may determine, in its sole
discretion. Such shares may be subject to such contingencies and restrictions as
the Committee may determine, as set forth in the Contract. Upon the issuance of
the stock certificate for a share Award, or in the case of uncertificated
shares, the entry on the books of the Company's transfer agent representing such
shares, notwithstanding any contingencies or restrictions to which the shares
are subject, the Award holder shall be considered to be the record owner of the
shares, and


                                      B-5
<PAGE>

subject to the contingencies and restrictions set forth in the Award, shall have
all rights of a stockholder of record with respect to such shares, including the
right to vote and to receive distributions. Upon the occurrence of any such
contingency or restriction, the Award holder may be required to forfeit all or a
portion of such shares back to the Company. The shares shall vest in the Award
holder when all of the restrictions and contingencies lapse. Accordingly, the
Committee may require that such shares be held by the Company, together with a
stock power duly endorsed in blank by the Award holder, until the shares vest in
the Award holder.

          7. TERMINATION OF RELATIONSHIP. Except as may otherwise be expressly
provided in the applicable Contract, if an Award holder's relationship with the
Company, its Subsidiaries and Parent as an employee or a consultant has
terminated for any reason (other than as a result of his death or Disability),
the Award holder may exercise the options and SARs granted to him as an employee
of, or consultant to, the Company or any of its Subsidiaries, to the extent
exercisable on the date of such termination, at any time within three months
after the date of termination, but not thereafter and in no event after the date
the Award would otherwise have expired; provided, however, that if such
relationship is terminated either (a) for Cause (as defined in Paragraph 18), or
(b) without the consent of the Company, such option shall terminate immediately.

          For the purposes of the Plan, an employment relationship shall be
deemed to exist between an individual and the Company, any of its Subsidiaries
or a Parent if, at the time of the determination, the individual was an employee
of such corporation for purposes of Section 422(a) of the Code. As a result, an
individual on military, sick leave or other bona fide leave of absence shall
continue to be considered an employee for purposes of the Plan during such leave
if the period of the leave does not exceed 90 days, or, if longer, so long as
the individual's right to reemployment with the Company, any of its Subsidiaries
or a Parent is guaranteed either by statute or by contract. If the period of
leave exceeds 90 days and the individual's right to reemployment is not
guaranteed by statute or by contract, the employment relationship shall be
deemed to have terminated on the 91st day of such leave.

          Except as may otherwise be expressly provided in the applicable
Contract, options and SARs granted under the Plan shall not be affected by any
change in the status of the Award holder so long as he continues to be an
employee of, or a consultant to, the Company, or any of its Subsidiaries or a
Parent (regardless of having changed from one to the other or having been
transferred from one corporation to another).

          Except as may otherwise be expressly provided in the applicable
Contract, if an Award holder's relationship with the Company as an Outside
Director ceases for any reason (other than as a result of his death or
Disability) then options and SARs granted to such holder as an Outside Director
may be exercised, to the extent exercisable on the date of such termination, at
any time within three months after the date of termination, but not thereafter
and in no event after the date the Award would otherwise have expired; provided,
however, that if such relationship is terminated for Cause, such Award shall
terminate immediately. An Award granted to an Outside


                                      B-6
<PAGE>

Director, however, shall not be affected by the Award holder becoming an
employee of, or consultant to, the Company, any of its Subsidiaries or a Parent.

          Except as may otherwise be expressly provided in the Contract, upon
the termination of the relationship of an Award holder as an employee of, or
consultant to, the Company, and its Subsidiaries and Parent, or as an Outside
Director, for any reason (including his death or Disability), the share Award
shall cease any further vesting and the unvested portion of such Award as of the
date of such termination shall be forfeited to the Company for no consideration.

          Nothing in the Plan or in any Award granted under the Plan shall
confer on any Award holder any right to continue in the employ of, or as a
consultant to, the Company, any of its Subsidiaries or a Parent, or as a
director of the Company, or interfere in any way with any right of the Company,
any of its Subsidiaries or a Parent to terminate the Award holder's relationship
at any time for any reason whatsoever without liability to the Company, any of
its Subsidiaries or a Parent.

          8. DEATH OR DISABILITY. Except as may otherwise be expressly provided
in the applicable Contract, if an Award holder dies (a) while he is an employee
of, or consultant to, the Company, any of its Subsidiaries or a Parent, (b)
within three months after the termination of such relationship (unless such
termination was for Cause or without the consent of the Company) or (c) within
one year following the termination of such relationship by reason of his
Disability, the options and SARs that were granted to him as an employee of, or
consultant to, the Company or any of its Subsidiaries, may be exercised, to the
extent exercisable on the date of his death, by his Legal Representative (as
defined in Paragraph 18) at any time within one year after death, but not
thereafter and in no event after the date the option would otherwise have
expired.

          Except as may otherwise be expressly provided in the applicable
Contract, if an Award holder's relationship as an employee of, or consultant to,
the Company, any of its Subsidiaries or a Parent has terminated by reason of his
Disability, the options and SARs that were granted to him as an employee of, or
consultant to the Company or any of its Subsidiaries may be exercised, to the
extent exercisable upon the effective date of such termination, at any time
within one year after such date, but not thereafter and in no event after the
date the option would otherwise have expired.

          Except as may otherwise be expressly provided in the applicable
Contract, if an Award holder's relationship as an Outside Director terminates as
a result of his death or Disability, the options and SARs granted to him as an
Outside Director may be exercised, to the extent exercisable on the date of such
termination, at any time within one year after the date of termination, but not
thereafter and in no event after the date the Award would otherwise have
expired. In the case of the death of the Award holder, the Award may be
exercised by his Legal Representative.


                                      B-7
<PAGE>

          9. COMPLIANCE WITH SECURITIES LAWS. It is a condition to the issuance
of any share Award and exercise of any option or SAR that either (a) a
Registration Statement under the Securities Act of 1933, as amended (the
"Securities Act"), with respect to the shares of Common Stock to be issued upon
such grant or exercise shall be effective and current at the time of exercise,
or (b) there is an exemption from registration under the Securities Act for the
issuance of the shares of Common Stock upon such exercise. Nothing herein shall
be construed as requiring the Company to register shares subject to any Award
under the Securities Act or to keep any Registration Statement effective or
current.

          The Committee may require, in its sole discretion, as a condition to
the receipt of an Award or the exercise of any option or SAR that the Award
holder execute and deliver to the Company his representations and warranties, in
form, substance and scope satisfactory to the Committee, which the Committee
determines are necessary or convenient to facilitate the perfection of an
exemption from the registration requirements of the Securities Act, applicable
state securities laws or other legal requirement, including, without limitation,
that (a) the shares of Common Stock to be received under the Award or issued
upon the exercise of the option or SAR are being acquired by the Award holder
for his own account, for investment only and not with a view to the resale or
distribution thereof, and (b) any subsequent resale or distribution of shares of
Common Stock by such Award holder will be made only pursuant to (i) a
Registration Statement under the Securities Act which is effective and current
with respect to the shares of Common Stock being sold, or (ii) a specific
exemption from the registration requirements of the Securities Act, but in
claiming such exemption, the Award holder shall prior to any offer of sale or
sale of such shares of Common Stock provide the Company with a favorable written
opinion of counsel satisfactory to the Company, in form, substance and scope
satisfactory to the Company, as to the applicability of such exemption to the
proposed sale or distribution.

          In addition, if at any time the Committee shall determine, in its sole
discretion, that the listing or qualification of the shares of Common Stock
subject to any Award or option on any securities exchange, Nasdaq or under any
applicable law, or the consent or approval of any governmental agency or
regulatory body, is necessary or desirable as a condition to, or in connection
with, the granting of an Award or the issuing of shares of Common Stock
thereunder, such Award may not be granted and such option or SAR may not be
exercised in whole or in part unless such listing, qualification, consent or
approval shall have been effected or obtained free of any conditions not
acceptable to the Committee.

          10. AWARD CONTRACTS. Each Award shall be evidenced by an appropriate
Contract which shall be duly executed by the Company and the Award holder, and
shall contain such terms, provisions and conditions not inconsistent herewith as
may be determined by the Committee. The terms of each Award and Contract need
not be identical.

          11. ADJUSTMENTS UPON CHANGES IN COMMON STOCK. Notwithstanding any
other provision of the Plan, in the event of a stock dividend, recapitalization,
merger in which the Company is the surviving corporation, spin-off, split-up,
combination or exchange of shares or the like which results in a change in the
number or kind of shares of


                                      B-8
<PAGE>

Common Stock which is outstanding immediately prior to such event, the aggregate
number and kind of shares subject to the Plan, the aggregate number and kind of
shares subject to each outstanding Award, the exercise price of each option, the
base price of each SAR, any contingencies and restrictions based on the number
or kind of shares, and the 162(m) Maximum shall be appropriately adjusted by the
Board of Directors, whose determination shall be conclusive and binding on all
parties. Such adjustment may provide for the elimination of fractional shares
which might otherwise be subject to Awards without payment therefor.

          In the event of (a) the liquidation or dissolution of the Company, (b)
a merger in which the Company is not the surviving corporation or a
consolidation, or (c) any transaction (or series of related transactions) in
which (i) more than 50% of the outstanding Common Stock is transferred or
exchanged for other consideration or (ii) shares of Common Stock in excess of
the number of shares of Common Stock outstanding immediately preceding the
transaction are issued (other than to stockholder of the Company with respect to
their shares of stock in the Company, any outstanding options, SARs or unvested
stock shall terminate upon the earliest of any such event, unless other
provision is made therefor in the transaction.

          12. AMENDMENTS AND TERMINATION OF THE PLAN. The Plan was adopted by
the Board of Directors on November 12, 1999. No ISO may be granted under the
Plan after November 12, 2009. The Board of Directors, without further approval
of the Company's stockholders, may at any time suspend or terminate the Plan, in
whole or in part, or amend it from time to time in such respects as it may deem
advisable, including, without limitation, in order that ISOs granted hereunder
meet the requirements for "incentive stock options" under the Code, to comply
with the provisions of Rule 16b-3, Section 162(m) of the Code, or any change in
applicable law, regulations, rulings or interpretations of any governmental
agency or regulatory body; provided, however, that no amendment shall be
effective without the requisite prior or subsequent stockholder approval which
would (a) except as contemplated in Paragraph 11, increase the maximum number of
shares of Common Stock for which Awards may be granted under the Plan or the
162(m) Maximum, (b) change the eligibility requirements to receive Awards
hereunder, or (c) make any change for which applicable law, regulation, ruling
or interpretation by the applicable governmental agency or regulatory authority
requires stockholder approval. No termination, suspension or amendment of the
Plan shall adversely affect the rights of any Award holder under an Award
without his prior consent. The power of the Committee to construe and administer
any Awards granted under the Plan prior to the termination or suspension of the
Plan nevertheless shall continue after such termination or during such
suspension.

          13. NON-TRANSFERABILITY. No option or SAR granted under the Plan shall
be transferable otherwise than by will or the laws of descent and distribution,
and options and SARs may be exercised, during the lifetime of the Award holder,
only by him or his Legal Representatives. Except as may otherwise be expressly
provided in the Contract, a stock Award, to the extent not vested, shall not be
transferable otherwise than by will or the laws of descent and distribution.
Except to the extent provided above, Awards may not be assigned, transferred,
pledged, hypothecated or disposed of in any way (whether by operation of law or
otherwise) and shall not be subject to execution, attachment or similar process,
and any such attempted


                                      B-9
<PAGE>

assignment, transfer, pledge, hypothecation or disposition shall be null and
void ab initio and of no force or effect.

          14. WITHHOLDING TAXES. The Company, a Subsidiary or Parent may
withhold (a) cash or (b) with the consent of the Committee, shares of Common
Stock to be issued under a stock Award or upon exercise of an option or SAR
having an aggregate Fair Market Value on the relevant date, or a combination of
cash and shares having such value, in an amount equal to the amount which the
Committee determines is necessary to satisfy the obligation of the Company, any
of its Subsidiaries or a Parent to withhold federal, state and local taxes or
other amounts incurred by reason of the grant, vesting, exercise or disposition
of an Award, or the disposition of the underlying shares of Common Stock.
Alternatively, the Company may require the holder to pay to the Company such
amount, in cash, promptly upon demand.

          15. LEGENDS; PAYMENT OF EXPENSES. The Company may endorse such legend
or legends upon the certificates for shares of Common Stock issued under a stock
Award or upon exercise of an option or SAR under the Plan and may issue such
"stop transfer" instructions to its transfer agent in respect of such shares as
it determines, in its discretion, to be necessary or appropriate to (a) prevent
a violation of, or to perfect an exemption from, the registration requirements
of the Securities Act and any applicable state securities laws, (b) implement
the provisions of the Plan or any agreement between the Company and the Award
holder with respect to such shares of Common Stock, or (c) permit the Company to
determine the occurrence of a "disqualifying disposition," as described in
Section 421(b) of the Code, of the shares of Common Stock issued or transferred
upon the exercise of an ISO granted under the Plan.

          The Company shall pay all issuance taxes with respect to the issuance
of shares of Common Stock under a stock Award or upon the exercise of an option
or SAR granted under the Plan, as well as all fees and expenses incurred by the
Company in connection with such issuance.

          16. USE OF PROCEEDS. The cash proceeds received upon the exercise of
an option, or grant of a stock Award under the Plan shall be added to the
general funds of the Company and used for such corporate purposes as the Board
of Directors may determine.

          17. SUBSTITUTIONS AND ASSUMPTIONS OF AWARDS OF CERTAIN CONSTITUENT
CORPORATIONS. Anything in this Plan to the contrary notwithstanding, the Board
of Directors may, without further approval by the stockholders, substitute new
Awards for prior options, SARs or restricted stock of a Constituent Corporation
(as defined in Paragraph 18) or assume the prior options or restricted stock of
such Constituent Corporation.

          18. DEFINITIONS. For purposes of the Plan, the following terms shall
be defined as set forth below:


                                      B-10
<PAGE>

             (a) "Cause" shall mean (i) in the case of an employee or
consultant, if there is a written employment or consulting agreement between the
Award holder and the Company, any of its Subsidiaries or a Parent which defines
termination of such relationship for cause, cause as defined in such agreement,
and (ii) in all other cases, cause as defined by applicable state law.

             (b) "Constituent Corporation" shall mean any corporation which
engages with the Company, any of its Subsidiaries or a Parent in a transaction
to which Section 424(a) of the Code applies (or would apply if the option
assumed or substituted were an ISO), or any Subsidiary or Parent of such
corporation.

             (c) "Disability" shall mean a permanent and total disability within
the meaning of Section 22(e)(3) of the Code.

             (d) "Exchange Act" means the Securities Exchange Act of 1934, as
amended.

             (e) "Fair Market Value" of a share of Common Stock on any day shall
mean (i) if the principal market for the Common Stock is a national securities
exchange, the average of the highest and lowest sales prices per share of Common
Stock on such day as reported by such exchange or on a composite tape reflecting
transactions on such exchange, (ii) if the principal market for the Common Stock
is not a national securities exchange and the Common Stock is quoted on Nasdaq,
and (A) if actual sales price information is available with respect to the
Common Stock, the average of the highest and lowest sales prices per share of
Common Stock on such day on Nasdaq, or (B) if such information is not available,
the average of the highest bid and lowest asked prices per share of Common Stock
on such day on Nasdaq, or (iii) if the principal market for the Common Stock is
not a national securities exchange and the Common Stock is not quoted on Nasdaq,
the average of the highest bid and lowest asked prices per share of Common Stock
on such day as reported on the OTC Bulletin Board Service or by National
Quotation Bureau, Incorporated or a comparable service; provided, however, that
if clauses (i), (ii) and (iii) of this subparagraph are all inapplicable, or if
no trades have been made or no quotes are available for such day, the Fair
Market Value of a share of Common Stock shall be determined by the Board of
Directors by any method consistent with applicable regulations adopted by the
Treasury Department relating to stock options.

             (f) "Legal Representative" shall mean the executor, administrator
or other person who at the time is entitled by law to exercise the rights of a
deceased or incapacitated optionee with respect to an option granted under the
Plan.

             (g) "Nasdaq" shall mean the Nasdaq Stock Market.

             (h) "Outside Director" shall mean a person who is a director of the
Company, but on the date of grant is not an employee of, or consultant to, the
Company, any of its Subsidiaries or a Parent.


                                      B-11
<PAGE>

             (i) "Parent" shall have the same definition as "parent corporation"
in Section 424(e) of the Code.

             (j) "Rule 16b-3" shall mean Rule 16b-3 promulgated under the
Exchange Act, as the same may be in effect and interpreted from time to time.

             (k) "Subsidiary" shall have the same definition as "subsidiary
corporation" in Section 424(f) of the Code.

          19. GOVERNING LAW; CONSTRUCTION. The Plan, the Awards and Contracts
hereunder and all related matters shall be governed by, and construed in
accordance with, the laws of the State of Delaware, without regard to conflict
of law provisions that would defer to the substantive laws of another
jurisdiction.

          Neither the Plan nor any Contract shall be construed or interpreted
with any presumption against the Company by reason of the Company causing the
Plan or Contract to be drafted. Whenever from the context it appears
appropriate, any term stated in either the singular or plural shall include the
singular and plural, and any term stated in the masculine, feminine or neuter
gender shall include the masculine, feminine and neuter.

          20. PARTIAL INVALIDITY. The invalidity, illegality or unenforceability
of any provision in the Plan, any Award or Contract shall not affect the
validity, legality or enforceability of any other provision, all of which shall
be valid, legal and enforceable to the fullest extent permitted by applicable
law.

          21. STOCKHOLDER APPROVAL. The Plan shall be subject to approval by a
majority of the votes present in person or by proxy and entitled to vote hereon
at the next duly held meeting of the Company's stockholders at which a quorum is
present. No Award granted hereunder may vest or be exercised prior to such
approval; provided, however, that the date of grant of any Award shall be
determined as if the Plan had not been subject to such approval. Notwithstanding
the foregoing, if the Plan is not approved by a vote of the stockholders of the
Company on or before April 9, 1998, the Plan and any Awards granted hereunder
shall terminate.

                                      B-12



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission